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Abstract 
Background: The number of patient~ in the United States living with chronic conditions is 
increasing as patients are surviving conditions that were previously fatal. This increase in 
survival has resulted in a shift in the disease burden in the United States from infectious to 
chronic diseases. Many patients with chronic conditions experience associated symptoms that 
impact their health-related quality of life more significantly than those without associated 
symptoms. To enable patients to achieve what they determine to be an acceptable state of well-
being, health care providers must first be aware of the factors and the relationships among the 
factors that impact the perceptions patients have of their health-related quality of life. To 
comprehensively assess their patients, health care providers must incorporate their objective 
perspectives with the subjective perspectives of their patients. A comprehensive assessment will 
enhance the ability of health care providers to develop treatment plans that enable patients to 
achieve the state of well-being they desire. Beyond traditional health-related quality of life 
instruments, an instrument is needed to assess patients' perceptions of the impact symptoms 
associated with a chronic condition have on their health-related quality of life. The impact of 
symptoms associated with chronic conditions is the focus of this dissertation. 
Objective: The objective was first to conduct a review of the literature to define chronic wound 
pain, the focus of the study in this dissertation., as chronic wound pain is often under-assessed 
and under-treated as a result of inadequate knowledge related to this type of pain. The second 
objective was to develop a conceptual map illustrating the factors and the relationship among the 
factors that shape patients" perceptions of their health-related quality of life. The next objective 
was to develop a subjective health-related quality of life assessment instrument and to test the 
reliability and validity of the newly developed instrument among patients experiencing pain 
associated with chronic wounds. 
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Results: The concept of chronic wound pain was explored and included defining this type of 
pain and identifying its prevalence, pathophysiology, and dimensions. The Chronic 
IllnesslDisease States - Symptom Intrusiveness Model was developed to demonstrate the factors 
that contribute to patients' perceptions of their health-related quality of life and the Symptom 
Intrusiveness Rating Scale was developed as a method to subjectively assess patients' 
perceptions of their health-related quality of li£e. Validity and reliability testing of the new 
instrument was conducted among patients with chronic wound pain. Patients with chronic 
symptoms confirmed in cognitive pretesting that the items on the instrument were interpreted as 
intended. Experts in the field of health-related quality of life confirmed that the statements on the 
instrument were all relevant. Test retest confirmed reliability of the Symptom Intrusiveness 
Rating Scale when conducting retest 2 to 4 days after the initial survey. However, conducting a 
retest study 2 weeks after the initial survey was found not to be a feasible method of testing 
reliability in a patient population admitted to an acute care facility. 
Conclusion: A subjective assessment can be quantified by utilizing the newly developed 
Symptom Intrusiveness Rating Scale, an instrument that focuses on the impact symptoms 
associated with chronic conditions have on patients' health-related quality of life. A 
comprehensive assessment will enhance a health care provider's ability to develop treatment 
plans that will improve the potential for patients to achieve their desired state of well being. 
Future research will focus on testing the validity and reliability of Sy IRS in studies with larger 
sample sizes and participants with varied chronic symptoms. 
5 
Table of Contents 
Acknowledgements ............................................................................................................................................ 2 
Abstract .............................................................................................................................................................. 3 
Introduction ........................................................................................................................................................ 6 
Chronic Wound Pain: An Exploratory Review of the Literature ..................................................................... 20 
The Chronic Illness/Disease States-Symptom Intrusiveness Model ................................................................ 35 
Initial Development of the Symptom Intrusiveness Rating Scale .................................................................... 53 
A Feasibility Pilot Study of the Symptom Intrusiveness Rating Scale: ........................................................... 72 
Conclusion/Summary ....................................................................................................................................... 99 
Appendix 1 Institutional Review Board Approval MUSC ......................................................................... 103 
Appendix 2 Institutional Review Board Approval SFH ................................................................................ 104 
Attachment 3 Consent Form .......................................................................................................................... 105 
Appendix 4 Protection of Human Subjects .................................................................................................... 111 
Appendix 5 Cognitive Pretesting Manual ...................................................................................................... 114 
Appendix 6 - Cognitive Pretesting Results .................................................................................................... 118 
Appendix 7 Interview Manual for Survey Administration ............................................................................ 120 
References ...................................................................................................................................................... 124 
6 
Introduction 
The disease burden in the United States has shifted from infectious diseases to chronic 
conditions, with chronic conditions currently accounting for 75% of health expenditures and 
deaths annually (1). By the year 2020, an estimated 80 million Americans will experience 
multiple chronic conditions (2). Because of the significant impact chronic conditions have on the 
health care system and patients' health-related quality of life (HRQoL), it is vital for health care 
providers (HCP) to develop an in-depth understanding of this impact and the most effective ways 
to assess and treat these conditions. The assessment of chronic conditions must include a HCP's 
objective assessment as well as a subjective assessment from the perspective of the patients 
experiencing the chronic conditions and associated symptoms. As part of an assessment, HCPs 
must recognize that patients who are experiencing symptoms related to chronic conditions will 
assess the impact of the conditions on their HRQoL differently than patients who are not 
experiencing symptoms associated with the conditions. A review of the literature identified 
research related to the impact chronic conditions have on patients' HRQoL, yet a gap was noted 
in research that focused on the impact symptoms associated with a chronic condition have a 
HRQoL. 
Responding to the need for such research, we first developed the Chronic Illness/Disease 
States - Symptom Intrusiveness Model (CIDS-SIM) to illustrate how symptoms associated with 
chronic conditions can impact patients' HRQoL. The development ofCIDS·SIM is underpinned 
by the Complexity Theory that includes four assumptions which indicate: (a) the relationship 
between patients and their HCP is impacted by social determinants of health and HRQoL, (b) 
anyone concept mayor may not lead to a predictable change, ( c) new behaviors will occur as a 
result of relationships patients have with others, and (d) factors that are blended can impact an 
outcome (3). The first section of CIOS-SIM identifies factors that have an effect on the 
interaction patients have with their HCP. In the next section, CIOS-SIM illustrates that the 
outcome of this interaction impacts the perception patients have of symptom intrusiveness, the 
degree to which patients determine the symptoms associated with chronic conditions are 
intruding on their HRQoL. This section also identifies factors that contribute to patients' 
perceived degree of symptom intrusiveness. The third and final section of eIOS-SIM identifies 
the components that define HRQoL and also describes that the perceived degree of symptom 
intrusiveness will affect the perception patient&have of their HRQoL. 
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It is often necessary to quantify the degree to which a symptom is impacting on patients' 
HRQoL to determine needed treatment and to evaluate the outcome of the treatment. Since the 
impact symptoms associated with chronic conditions have on patients' HRQoL can be assessed 
most accurately with input from the patients experiencing the symptoms, patients' subjective 
perspective should be included in the assessment. However, in the literature there is no evidence 
that revealed an instrument intended to subjectively assess and quantify the impact symptoms 
associated with chronic conditions have on patients' HRQoL. The Illness Intrusiveness Rating 
Scale (IIRS) developed by Dr. G. Devins (4) was identified, during the review of the literature, 
as an instrument that could be adapted to focus specifically on the impact of the symptoms of a 
chronic condition. The adapted instrument was titled the Symptom Intrusiveness Rating Scale 
(SyIRS). A study was conducted to test, first the feasibility of utilizing SyIRS to assess the 
perceptions patients have developed of the impact symptoms associated with a chronic condition 
have on their HRQoL. The validity and reliability of the instrument were also tested in this study 
which was conducted among a population experiencing pain associated with chronic wounds. 
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Pain 
Pain, the most common reason for patients to seek medical care (5), has been defined in 
numerous ways by various individuals, groups, and organizations. In 1933 the Oxford English 
Dictionary defined pain as "a primary condition of sensation or consciousness, the opposite of 
pleasure; the sensation which one feels when hurt (in body or mind); suffering, distress" (p. 377) 
(6). The most widely accepted definition of pain was posited by the International Association for 
the Study of Pain (IASP) (1994), which defined pain as "an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage" (para 1). The IASP and many others who have extensively studied the pain 
phenomenon agree that pain is subjective (7-9). Patients' perceptions of their pain are affected 
by pervious experiences, emotional states, mental states, and cultural background (10-12). 
Pain is a phenomenon experienced by most people at some point in life (1). It is also a 
sensation people fear and that can cause great distress and even disability. As such, pain, both 
acute and chronic, has been shown to be the factor with the greatest negative impact on patient's 
health-related quality of life (HRQoL) (13-15), affecting functional status and well-being (16). 
Acute pain is a beneficial type of pain as it signals patients that something is wrong and that 
action must be taken to prevent further inj ury (1 7). Chronic pain does not serve the same 
protective purpose as acute pain (5). It does not alert the body to injury, but instead can exist 
without any additional peripheral pain input (18). 
Chronic Pain 
Chronic pain is an experience as opposed to an expression of the immediacy of acute pain 
(19), a symptom that overwhelms all other symptoms and impacts a person's ability to work, eat, 
sleep, and be physically active (20). The time for which pain is considered to be chronic has been 
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defined in multiple ways. The IASP defines chronic pain as "pain that persists beyond normal 
tissue healing time, which is assumed to be 3 months" (p. 1250) (21). Pain is often deemed to be 
chronic if it lasts longer than 6 weeks (22); however, more recent research has noted that 
elements of chronic pain can be distinguished much earlier than 6 weeks post-injury (23). Pain 
has also been determined to be chronic if the pain has existed for 6 or more months in the 
previous year (24). In a survey conducted by the American Pain Society (2011), the more 
common type of chronic pain was one that flared frequently and was present on average almost 6 
days per week. Almost 33% of those surveyed described their chronic pain as the worst pain they 
could possibly imagine and 660/0 of the respondents have been living with pain for more than 5 
years (20). 
Chronic pain is commonly a result of low back pain, headache, arthritis, nerve damage, 
cancer, and other conditions (20). A common cause of disability, chronic pain is not often 
curable yet it is manageable (25). HCPs who do not treat or who under-treat chronic pain do so, 
in part, because they lack adequate knowledge of chronic pain (25) and they often doubt the 
credibility of the patient claiming to experience chronic pain (19). Chronic pain is a self-reported 
condition, and HCPs often explain chronic pain as a psychological issue (26). As a result, 
patients are often afraid to report chronic pain for fear of the psychological label applied. If 
chronic pain is to be properly addressed, patients must be encouraged to discuss any chronic pain 
they are experiencing, its intensity, duration, location, onset, and triggers. They must also be 
encouraged to discuss feelings of anxiety, depression, or anger associated with their pain. In 
order to effectively treat those who express their chronic pain experience, Heps need to be aware 
of signs of chronic pain and behaviors exhibited by those experiencing chronic pain (26). 
Communication between HCPs and patients experiencing chronic pain is vital to overcoming 
these barriers and developing an effective management/treatment plan 
Chronic Wound Pain 
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Chronic wound pain is a background symptom that can be intermittent or persistent and 
exists at rest, between wound-related procedures and/or when repositioning (27). It often does 
not have a specific trigger. Instead, chronic wound pain is often associated with the cause of the 
wound and local changes in the wound environment (27). Chronic wound pain is often a 
combination of acute and chronic pain (9). 
Prevalence 
Multiple attempts have been made to estimate the prevalence of chronic pain in the 
United States. Study results indicate 20% to 60% of Americans experience chronic pain (28). A 
survey conducted by the U.S. Department of Health and Human Services estimates that 26% or 
76.5 million Americans report experiencing pain that lasted longer than 24 hours. Of the 
Americans who report having experienced pain, 42% or 32.13 million report pain that has lasted 
longer than one year (29). 
In an Internet survey of27,035 adults 18 and older~ 30.7% noted pain that lasted longer 
than 6 months (30). This survey found that more females (64.8%) than males (35.2%) 
experienced chronic pain. When stratified by type of pain~ the prevalence of chronic lower back 
pain was similar in females and males. The overall prevalence of chronic pain increased with age 
with the exception of females over 65 in whom the prevalence decreased. When the data from 
this study were adjusted for all other sociodemographic factors, the rate of chronic pain increased 
among those who were unemployed due to disability and among those in the lowest level of 
household income « $25,000 per year) (30). 
In a study conducted in the US, the National Center for Health Statistics reported that 
42% of the respondents aged 20 and older and 57% of those aged 65 and older reported 
experiencing pain lasting 1 year or longer (5). A survey conducted by Research!America 
estimated that 100 million Americans experience chronic pain (31). A pharmaceutical 
corporation cited a survey indicating that 28% of the adult population or 56 million Americans 
experience chronic pain (32). Finally, it is estimated that 9% of the United States population 
experiences moderate to severe chronic pain and is more common in women than in men (29). 
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The prevalence of chronic wound pain,tofien associated with chronic wounds (33) is 
difficult to determine. Studies focused on the prevalence of chronic wound pain concluded that 
a majority of patients with chronic wounds experience wound pain to some extent (33, 34). A 
study by Phillips et al. noted that 87% of the participants in their study reported chronic wound 
pain as mild to severe (35). 
Dallam (1995) reported that 59% of study participants experienced some degree of 
chronic wound pain, yet only 2% received analgesics in a timely manner (36). Szor and 
Bourguignon (35) focused on chronic pressure ulcer pain and noted that 87% of the participants 
reported pain during dressing change, 84% reported pain at rest, and 42% reported that they 
experienced pain all the time. 
An estimated 80% of individuals with chronic wounds experience persistent pain with 
50% of those people rating the pain as moderate or the worst pain they have experienced (27, 33, 
34). Eighty percent of patients with chronic wounds experience pain that is persistent between 
dressing changes (27). 
Dimensions of pain 
The dimensions of pain, or the components that contribute to patients' perception of pain 
include biological, psychological, cultural (10), and previous experiences with pain (7). In 1965 
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when Melzack and Wall first formulated a description of the sensory transmission of a pain 
signal, they were aware that there was also an emotional and cognitive dimension related to the 
perception of pain (37). The three dimensions of the pain experience delineated by Melzack and 
Wall are: (a) sensory - the physical sensation, (b) affective - how pain affects a person's 
emotional state, and (c) cognitive - how a person makes sense of or explains his or her pain 
experience (37) A differentiation among patients experiencing chronic pain who have 
experienced previous trauma either physical or emotional and those who have not experienced 
trauma, is seen in the affective dimension of chronic pain (26). The cognitive dimension of 
chronic pain will be influenced by past experiences with pain, imagination, unconscious 
conflicts, and the significance of pain for the people experiencing it (26). 
Assessment 
An assessment that does not include an evaluation of all the dimensions of pain often 
results in the pain being under-estimated, under-assessed, under-treated and/or neglected by 
HCPs (38) Only an estimated 25% of those experiencing chronic pain receive appropriate 
treatment (32), and the lack of appropriate treatment is impacted by a lack of appropriate 
assessment due to the following: 
• The perception a health care provider (HCP) develops of a patient's pain which is 
impacted by factors including; lack of a laboratory test that can assess pain intensity 
(38), a HCP's lack of adequate knowledge related to the mechanisms of pain (39, 40), 
and ineffective communication between patients experiencing the pain and their HCP 
(17). 
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• HCP" s failure to believe a patient who states he or she is experiencing chronic pain 
(19). HCPs who do not treat patients" complaints of chronic pain as credible will most 
often not treat or under-treat the pain (19). 
• Financial barriers, treatment non-adherence, and lack of a relationship with a HCP 
(32) 
Acute pain, chronic pain, and chronic wound pain, which is often a combination of acute 
and chronic pain, must be managed appropriately as untreated pain or pain that is not under 
control has significant adverse effects on patients' perceptions of their HRQoL (29). Unrelieved 
pain can affect patients" ability to concentrate, maintain employment, exercise, socialize, sleep, 
participate in leisure .activities, maintain their home, andlor have intimate relations. Untreated or 
undertreated pain also impacts patients' psychological well-being, increasing the incidence of 
depression, irritability, listlessness creating feelings of inability to cope and uselessness (29). 
Therefore, since acute, chronic, and chronic wound pain affect multiple aspects of a patient's 
life; the most effective treatment includes not only treatment of the physical symptoms of pain 
but also treatment that addresses the impact on patients' HRQoL (20, 41). The goal of a pain 
management plan is to return patients to their desired level of functioning. The most appropriate 
approach to effective management is multifaceted. Evidence based practice for the treatment of 
chronic pain includes (a) medication management, (b) non-medication management, and (c) 
complementary and alternative medicine (28, 42, 43). 
An effective management/treatment plan for those experiencing chronic pain and chronic 
wound pain can impact patients in multiple ways enabling them to maintain their well-being and 
HRQoL (2). Effectively managing chronic pain and chronic wound pain will enable many 
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patients to maintain social relationships (44), vitality, and mental health (4, 45, 46) all which 
contribute to maintaining or improving ones sense of well-being and HRQoL (13). 
Symptoms associated with chronic conditions often have a negative impact on patients' 
HRQoL, thus an assessment of these symptoms must be addressed from the perspective of the 
Heps as well as from the perspective of the patients experiencing the symptoms. The work 
presented here explores the need for such an assessment by first presenting CIDS-SIM, an 
illustration of the factors and the relationship among the factors, which contribute to the 
perception patients have of the impact symptoms associated with a chronic condition have on 
their HRQoL. Next, SyIRS, a novel HRQoL assessment instrument that focuses on symptoms 
associated with chronic conditions, is presented as a way to subjectively assess the impact of 
.. 
symptoms associated with chronic conditions. To address the focus of the study conducted, the 
phenomenon of pain is explored including acute pain, chronic pain, and pain associated with 
chronic wounds. Finally, the results of a feasibility pilot study conducted among patients 
experiencing pain related to chronic wounds are presented. The goal of this work is to enhance 
the assessment HCPs conduct of patients who are experiencing symptoms associated with 
chronic conditions., thus improving the potential for patients experiencing this pain to achieve a 
HRQoL which they determine to be acceptable. 
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Purpose: Patients experiencing chronic wound pain state that relief of pain is most often their 
highest priority in treatment; yet chronic wound pain is often inadequately assessed, which can 
lead to the development of a treatment plan that does not sufficiently address pain relief. An 
inadequate assessment of chronic wound pain can result in patients experiencing unnecessary 
pain which can significantly impact their health-related quality of life. Factors that, in part, 
contribute to an ineffective assessment of chronic wound pain include lack of consensus among 
health care providers regarding the definition of chronic wound pain, lack of knowledge 
regarding the mechanisms of pain, lack of awareness of the complexity of chronic wound pain" 
and lack of differentiation between acute pain and chronic pain as each relates to chronic wound 
pain. The purpose of this review is to serve as a starting point for an exploration of the concept of 
chronic wound pain including its pathophysiology, dimensions, and current definitions. The 
prevalence of acute, chronic, and chronic wound pain is also reviewed to support the need for 
further research in this field based on the number of patients experiencing chronic wound pain 
and the burden on the health care system. 
Design: The design for this evaluation of the literature is an exploratory review. 
Method: A literature search was conducted in the Ovid Medline, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), PsycINFO, and PsycARTICLES electronic databases. 
Medical subject headings (MeSH) and keywords used for this review were wound and injuries, 
chronic wound, pain, chronic pain, and prevalence. The search was limited to articles in English 
and related to humans. 
Results: Twenty-three articles were identified as relevant to this review. In addition to articles 
that represent current knowledge, seminal research was also identified for inclusion in this 
reVIew. 
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Conclusions: Chronic wound pain is prevalent in the United States and significantly impacts 
those experiencing it. Chronic wound pain also poses a significant financial impact on the health 
care system. Although chronic wound pain significantly impacts patients and the health care 
system, this complex type of pain is often inadequately assessed resulting in treatment that does 
not sufficiently address pain. To improve patieQ.t outcomes and to decrease the financial burden 
on the health care system, health care providers need to assess chronic wound pain more 
effectively which will enhance their ability to develop treatment plans that more effectively 
address pain. Health care providers need to come to consensus on the definition of chronic 
wound pain, realize the complexity of chronic wound pain which has a physiological and 
emotional component, and develop their understanding of the pathophysiology of chronic wound 
paIn. 
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Chronic Wound Pain: An Exploratory Review of the Literature 
Pain is a symptom related to numerous medical conditions and the most common reason 
people seek medical care (1). It is a phenomenon experienced by most people at some point in 
their lives that causes great distress and disability (2). Pain also has a significant financial impact 
with health care costs and lost productivity related to pain estimated to be $61.2 billion annually 
in the United States (3). In studies related to a more specific type of pain, chronic wound pain, 
nearly 800/0 of people with chronic wounds experience pain either intermittently, continuously, or 
during procedures (4). 
Although pain has a significant effect on people and the health care system, it is often 
under-estimated and under-treated (4). This pattern is found among multiple health care 
providers (HCPs) including physicians, nurses, and other health care professionals and across 
multiple settings including inpatient, outpatient, emergency departments, and long term care (5). 
One factor in the under-estimation and under-treatment of pain is inadequate knowledge among 
Heps of pain (5). Pain, both acute and chronic, differs in function and benefit. Acute pain is a 
beneficial type of pain, providing a signal that something is physically wrong and that action 
must be taken to prevent further injury (6). In contrast, chronic pain serves no useful purpose and 
does not protect a person from further tissue damage (7). Pain associated with chronic wounds 
can be acute and/or chronic and can significantly impact patients' health-related quality of life 
(HRQoL) (4). Therefore, to effectively assess and treat chronic wound pain HCPs need to have a 
thorough understanding of the pathophysiology of acute and chronic pain and the dimensions of 
each type of pain. 
The research questions that guided this review are: 
1. What is the prevalence of acute pain, chronic pain, and chronic wound pain? 
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2. What is the pathophysiology of acute, chronic, and chronic wound pain? 
3. What are the dimensions of pain? 
Literature Review 
A comprehensive, computer-assisted search of the literature was conducted in the Ovid 
Medline, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycINFO, and 
PsycARTICLES electronic databases to identify the pathophysiology, pathways, and dimensions 
of chronic wound pain. The review was limited to English and humans, and to manuscripts 
included in the electronic databases from inception of the databases through January 2012. In 
Ovid Medline, the MeSH term pain (69718) was combined with the keyword chronic wound 
(571) resulting in 15 abstracts. In CINAHL, PsycINFO, and PsycARTICLES, the MeSH term 
wound and injuries (9043) was combined with the MeSH term pain (86072), and the keyword 
chronic (113798) which resulted in 29 abstracts. These abstracts were reviewed for relevancy to 
this review. Twenty manuscripts were identified. Seminal research related to the 
pathophysiology and dimensions of pain was also identified. 
The electronic databases were also searched for prevalence data related to pain. The 
MeSH term chronic pain (8440) was combined with the MeSH term prevalence (582) resulting 
in 89 abstracts. After review, three manuscripts were identified as relevant to this review. 
Prevalence 
Limited studies have been conducted regarding the prevalence of pain, yet these studies 
indicate that acute, chronic, and chronic wound pain are significant in the United States. Table 2 
notes the results of studies regarding the prevalence of pain. 
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Table 2 Pain prevalence 
TYPE OF SOURCE DESIGN/SUBJECTS N PREVALENCE 
PAIN 
Acute National Center for Health Population based 9,900 26% 
Statistics Trends in the Health survey of peop Ie over 
q( Americans (8) the age of20 
Chronic Hardt review of the National Random web-based 10,271 14.6%) 
Health and Nutrition survey 
Examination Survey 
(NHANES) (9) 
Clark (10) Retrospective medical 300 50% 
record review 
National Center for Health Population based 9,900 560/0 
Statistics Trends in the Health survey of people over 
of Americans (8) the age 0£20 
Chronic Phillips (11 ) Retrospective study of 73 590/0 
wound people with lower 
extremity wounds 
Dallam (12) Cross-sectional study 132 87% during dressing change 
of people with chronic 84% at rest 
pressure ulcers 42% all the time 
Pathophysiology 
Pathways 
The first attempt to understand pain pathways was made by Rene Descartes in 1664 and 
published in the Treatise of Man (13). The theory proposed that the transmission of pain was 
through a single channel from the skin to the brain. Descartes believed that when a person came 
in contact with a noxious stimulus, the skin in the area involuntarily moved, causing a thread to 
be pulled that opened a small valve in the brain through which animal spirits would travel to the 
muscles causing the withdrawal of the body part from the stimulus (13). 
A more definitive theory of the pain pathways did not occur until the 20th century. In 
1965, Melzack and Wall proposed a theory of pain pathways termed the Gate Control Theory 
(14). This theory posits that when an injury occurs there is a release of inflammatory mediators 
that cause the excitation of pain receptors in the area of the injury. Pain messages that originate 
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in the nerves associated with the damaged tissue travel along the peripheral nerves to the dorsal 
hom of the spinal cord and then to the brain. Melzack and Wall proposed that before the 
impulses can reach the brain, they encounter nerve gates in the dorsal hom substantia gelatinosa 
in the spinal cord. Small nerve fibers or pain receptors open the gate and allow the transmission 
of the signal. Large nerve fibers, normal receptors, promote the closing of the gate; therefore~ 
the signal is not transmitted and pain is not perceived. Emotional factors including previous 
experiences with pain, culture, stress~ and environment can affect the opening or closing of the 
gates through the release of neurotransmitters. When the gates are open, the impulses pass 
through and travel to the brain, and pain is perceived (14). When the gates are closed secondary 
to a sufficient alternate impulse such as massage, acupuncture, or even downward messages from 
the brain, the impulses are kept from reaching the brain, thus preventing a perception of pain 
(15). The Gate Control Theory suggests that mechanisms in the central nervous system control 
the perception of a noxious stimulus that integrates the impulse moving toward the central 
nervous system with the downward modulating or tempering process from the brain (14). This 
explains why similar stimuli can evoke different responses in different people. 
Acute pain 
Acute pain is incited by tissue damage and persists for varying lengths of time until 
healing takes place (16). It is perceived quickly as a result of a specific injury and is relatively 
short-lived. Acute pain is associated with hyperactivity of the sympathetic nervous system 
producing tachycardia, increased respiratory rate and blood pressure, diaphoresis, and dilated 
pupils (17). It follows nociceptive stimulation secondary to physical, thermal~ or chemical tissue 
injury (16). The processes involved in nociception are transduction, transmission, perception, 
and modulation. Transduction begins when nociceptors or C fibers and A-delta fibers respond to 
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stimuli. The stimulation causes a release of chemical mediators from the damaged cells. These 
mediators activate and/or sensitize the nociceptors to the stimuli. An exchange of sodium and 
potassium ions occurs at the level of the cell membrane. This exchange results in the initiation 
of a pain impulse. The pain impulse is transmitted to the neurons in the dorsal hom of the spinal 
cord where excitatory neurotransmitters are released. The impulse is then transmitted to the brain 
stem and thalamus where the pain is perceived. The pain impulse can be modulated by the 
release of neurotransmitters that block or partially block the transmission of the pain impulse 
(16). Acute pain is frequently well localized, constant, and time limiting indicating that this type 
of pain resolves as the injury improves and heals (17). Acute pain is beneficial since it provides a 
signal to a person that a change must be made to prevent further injury (6). 
Chronic Pain 
Chronic pain is defined by the International Association for the Study of Pain (IASP) as 
pain that persists beyond normal tissue healing time (18). The time frame for which pain is 
considered to be chronic has been defined in multiple ways. Pain is most often classified as 
chronic if it lasts longer than 6 weeks ( 19). However, more recent research has noted that 
elements of chronic pain can be distinguished much earlier than 6 weeks post-injury (20), and 
pain has also been determined to be chronic if the pain exists for 6 or more months in the 
previous year (21). Chronic pain is commonly associated with various medical conditions 
including diabetes, arthritis, migraine headaches, fibromyalgia, cancer, shingles, sciatica, and 
previous trauma or injury (22). The physiology of chronic pain remains unclear, yet it is thought 
to be a result of nerve damage due to degeneration, pressure, inflammation, or infection (16). 
When a nerve becomes damaged in one of these manners, it becomes electrically unstable, firing 
signals at inappropriate and random times, often in a disordered fashion. The associated pain is 
typically described as burning, shooting, stinging, or as a sensation of pins and needles (16). 
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A person experiencing chronic pain experiences an altered transmission of the normal pain 
pathways resulting in central and peripheral sensitization in which the pain sensation is sustained 
after nociceptive stimuli have ceased (23). Three of the common altered pain transmission 
pathways noted with chronic pain are wind-up, allodynia, and primary hyperalgesia (24). Wind-
up is a result of repeated stimulus of the same intensity which over time can lead to an increased 
neural response. Patients experience an increa$ed pain response to the same stimuli as a result of 
this altered pain pathway. Allodynia presents as an area of enhanced sensitivity around or near 
the original site of injury in which an extreme pain response is elicited as a result of harmless 
stimuli. Finally, primary hyperalgesia results from injury due to inflammation, infection, or 
ischemia which produce chemical mediators that activate or sensitize nociceptors. When the 
injury persists the threshold for activation of nociceptors is decreased and the response to the 
stimuli is enhanced which leads to increased sensitivity to the area of damage (24). 
Chronic wound pain 
Chronic wound pain, the pain associated with chronic wounds, is noted at rest, during 
wound-related procedures, and/or when repositioning (4, 25). Chronic wound pain is frequently 
associated with the cause of the wound and local changes in the wound environment (25). After 
the initial injury, pain related to wounds that do not heal within the normal or expected time 
frame can be classified as chronic pain when it is triggered by persistent inflammation or by 
stimulation of the release of mediators that activate local pain receptors. Wound pain can also be 
triggered by procedures such as debridement or dressing changes and be classified in these 
instances as acute pain (25). Krasner classified wound pain in relation to the cause, referring to 
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pain that occurs during single, non-repetitive procedures such as wound debridement as 
noncyclic acute pain (26). If the pain occurs during repeated activities such as dressing changes 
or position changes, the pain is referred to as cyclic acute pain. Pain that occurs without 
manipulation is referred to as persistent or chronic pain (26). Therefore, pain associated with 
chronic wounds is often a combination of acute and chronic pain. 
Pain dimensions 
Pain dimensions are defined as the components that contribute to patients' perceptions of 
pain and include sensory, affective, and evaluative elements (14). The sensory dimension refers 
to a patient's description of one's pain including the location, quality, intensity, and duration. 
These descriptors relate to the increased sensitivity of neurons following an injury (27). Pain 
noted by this dimension can be caused by ischemia, inflammation, and/or neuropathic 
mechanisms. Treatments such as wound debridement can also elicit this type of pain. The 
affective dimension is the emotional response patients have to the pain experience. It is the 
dimension that indicates how pain makes patients feel (27). The evaluative dimension refers to 
patients' sense of how the pain affects their HRQoL. This dimension illustrates that patients' 
perceptions of pain are impacted by reminders in the environment, such as previous pain 
experiences and culture. When the environmental reminders are reinforced, pain behavior is 
reinforced and pain is more likely to persist. The affective and evaluative dimensions dominate 
the chronic pain experience (14). 
Conclusions 
Chronic wound pain, which can be acute and/or chronic, is a symptom that patients 
experiencing it express to be their highest priority in regards to management and treatment of 
their condition; yet it is often under-assessed and under-treated (25). It is also a symptom that is 
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critically understudied and which poses significant challenges for the Heps. The prevalence of 
chronic wound pain, the impact it has on the health care system, and the lack of a clear 
understanding of this symptom confirm the need for further research related to the 
pathophysiology of this complex type of pain and effective ways to assess, manage, and treat 
patients experiencing it. Effective management and treatment will decrease the burden on 
patients with chronic wound pain and promote an improved state of well-being. The negative 
impact chronic wound pain has on patients' HRQoL is significant and therefore, should always 
be considered when assessing patients who express experiencing chronic wound pain. Further 
research is also needed regarding how this type of pain can be more effectively managed to 
improve patients' HRQoL. 
One factor that impacts the effectiveness of the assessment and treatment of patients with 
chronic wound pain is an Hep's knowledge that this type of pain can be acute andlor chronic as 
well as their knowledge of the pathophysiology and dimensions of acute and chronic pain. By 
understanding the differences between acute and chronic pain, the way patients describe and 
perceive their pain, and patients' emotional responses to pain, Heps will be able to effectively 
assess chronic wound pain. 
Many symptoms related to chronic conditions such as chronic wound pain have a 
physiological and psychological component that significantly impact multiple aspects of 
patients' lives including their HRQoL; therefore, future studies are needed that will lead to the 
development of a theory that focuses on symptoms associated with chronic conditions. The 
development of a theory needs to begin with a conceptual model that indicates the concepts 
related to symptoms of a chronic condition and the relationship among the concepts. 
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Further research is also needed regarding effective assessment of chronic symptoms 
including chronic wound pain. Quantifying the impact chronic symptoms have on patients' 
HRQoL which encompasses both physiologic and psychologic components related to chronic 
symptoms, will enhance HCPs ability to develop an effective treatment plan and to assess the 
efficacy of the plan. With an understanding of the complexity of chronic wound pain including 
the mechanisms and dimensions of pain as well as incorporating the patients' perspectives of the 
pain experience in their assessment, HCPs will improve their ability to more positively impact on 
patient outcomes. 
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Background: Patients indicate that symptoms they experience related to chronic conditions can 
significantly impact their health-related quality of life. Although this impact is considerable, 
there is limited related research and no theories were identified that addressed the intrusiveness 
of symptoms assoc~ated with chronic conditions on health-related quality of life. Therefore, the 
purpose was to identify components that contribute to patients' perceptions of how chronic 
symptoms impact their health-related quality of life and to develop a ~onceptual model that 
demonstrates the interaction among those components. 
Method: The method used for the development of this conceptual model was Fawcett's 
Conceptual-Theoretical-Empirical technique. 
Result: The Chronic IllnesslDisease State - Symptom Intrusiveness Model was developed to 
illustrate the relationship among patients' interactions with their health care provider, symptom 
intrusiveness, and health-related quality of life. In contrast to other theories that address effects 
of patients' conditions, this unique conceptual model specifically addresses symptoms of chronic 
conditions and the impact on health-related quality of life from the perspective of the patients 
experiencing them. 
Keywords: symptom, intrusiveness, chronic illness, chronic disease, health-related quality of 
life, patient-provider interaction, conceptual model 
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The Chronic IlInesslDisease States - Symptom Intrusiveness Model 
In the past century, the disease burden in the United States has shifted from infectious to 
chronic diseases, with chronic diseases accounting for 75% of health expenditures annually (1). 
Conftrming this shift, it is estimated that by the year 2020, 80 million Americans will experience 
chronic conditipns (2). 
Many patients with chronic conditions experience associated symptoms that can 
significantly impact their health-related quality of life (HRQoL). When addressing chronic 
conditions, health care providers (HCPs) often objectively assess the etiology of patients' 
conditions (3) by analyzing, in part, a physical exam, blood tests, and radiologic studies. An 
evaluation based on an objective assessment alone will not take into account patients' 
perspectives of how symptoms they are experiencing impact their HRQoL 
Through a comprehensive review of the literature, the Symptom Management Model was 
the only theory identified that addressed symptoms related to chronic conditions (4) and no 
theories were identified that addressed the intrusiveness of symptoms related to chronic 
conditions. Therefore, to address this gap, the Chronic IllnesslDisease State - Symptom 
Intrusiveness Model (CIDS-SIM) was developed (Appendix A) to incorporate patient~HCP 
interactions, patients' ~perspectives of symptom intrusiveness, and the impact of chronic 
symptoms on patients' HRQoL. This model has been adapted with permission from Leventhal's 
Common Sense Model (5) and Spirig's Symptom Management Model (4). CIDS-8IM is 
underpinned by four theories that support the inclusion of the components identified in the model 
and the influence these components have on the perception patients have of the impact their 
chronic symptoms have on their HRQoL. 
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This manuscript outlines the method used to develop the Chronic I lIne sslD i sease States -
Symptom Intrusiveness Model (CIDS-SIM). The assumptions made during the development of 
the model, the theories used to underpin CIOS-SIM, and the concepts and relationships among 
the concepts are discussed. 
Method 
Research should begin with a conceptual model to identify key concepts and loosely 
identify the relationship among the concepts (6, 7). CIDS-SIM, a model tpat identifies concepts 
related to symptom intrusiveness and HRQoL, is the foundation for research related to this 
phenomenon. We used Fawcett's Conceptual-Theoretical-Empirical (C-T ... E) technique to 
develop CIOS-SIM. The C-T .. E approach in the development of a conceptual model includes the 
following steps: (a) name the conceptual model and identify its concepts, (b) classify concepts 
based upon characteristics of observation and measurement, (c) identify the definitional and 
relational propositions, (d) identify the hierarchy of deductive reasoning, and (e) diagram the 
conceptual model's concepts and propositions (6). 
Assumptions 
Several assumptions were made in the development of CIOS-SIM. Symptoms of a 
chronic condition impact patients differently than a chronic condition without associated 
symptoms. It was also assumed that the symptoms of a chronic condition impact patients 
differently than acute symptoms. In addition, the outcome of an interaction among patients and 
their HCPs can and will be influenced by factors that affect this communication. The outcome of 
this interaction affects patients' perceived intrusiveness of their chronic symptoms and this 
perception, in turn, affects patients' HRQoL. Finally, we assume that patients' perceptions of 
their HRQoL will impact further interactions with their HCPs. 
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Theoretical and Conceptual Underpinnings 
F our theories provide the theoretical suPPort for inclusion of the concepts identified in 
CIOS-SIM. These theories underpin the concepts of patients' subjective perspectives, patients' 
symptom experiences, the impact of chronic symptoms on patients' well-being, and the affect of 
patient-HCP interactions on patients' outcomes and HRQoL (4, 8-10). These theoretical 
foundations support the concepts of CIOS-SIM (Table 1). 
The first theory is Leventhal's Common Sense Model (CSM), also known as the Illness 
Perception Model, the Illness Representations Model, the Self-Regulatory Model, and the 
Parallel Process Model (5). Leventhal began his research exploring fear messages in acute 
situations, noting that different types of information are needed to affect both attitudes and 
behaviors that patients have towards the perceived threat to health and well ... being. Expanding on 
this theory, Leventhal and his colleagues ·included adaptations and coping skills needed by those 
experiencing chronic conditions. Leventhal has described five concepts of illness representation 
including: (a) identity - the name given to a condition and·symptoms that relate to it, (b) cause-
patients' beliefs about the etiology of their condition which mayor may not be accurate, (c) 
time-line.;.. belief regarding how long the condition will last, (d) consequences - patients' beliefs 
about consequences of their condition and how these consequences will impact on their social 
and physical activities, and (e) curability/controllability - beliefs patients have regarding the 
curability of a condition arid the role they have in the curability (5). As noted in CSM, one major 
concept is patients' beliefs about their illness. These beliefs aid patients in making sense of their 
symptoms. CSM supports CIOS-SIM in addressing patients' subjective perspectives of their 
chronic illnesses and the perceived threats to their well-being. 
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Spirig adapted the CSM by introducing the concepts of symptom experience consisting of 
symptom occurrence and symptom distress to create the Symptom Management Model (SMM) 
(4). Symptom occurrence refers to the dimensions of symptom frequency, severity, and duration. 
Symptom distress reflects the emotional concepts including mental anguish and suffering. Spirig 
posits that patients' symptom experiences guide their actions. The symptom experiences patients 
have when combined with symptom management and treatment adherence determines their 
HRQoL. In contrast to Leventhal's CSM, Spirig places more importance on the social concepts 
of the SMM model indicating that social support is essential to symptom management and 
adherence (4). SMM supports CIDS-8IM in addressing patients' symptom experiences and its 
identified impact on their HRQoL. 
Devins described illness intrusiveness as resulting from "disease and treatment induced 
disruptions to lifestyles, activities, and interests" (8, p. 591). Devins indicates that illness 
intrusiveness is a basic determinant of the psychosocial impact of chronic diseases (8) that results 
from illness-induced obstacles that prevent patients from participating in desired activities and 
interests. Illness intrusiveness is comprised of psychological well-being and is associated with 
emotional distress in the reduction of (a) positive outcomes derived from valued activities and 
(b) patients' control by limiting the ability to achieve positive outcomes. Devins' model depicts 
how disease and treatment factors affect illness intrusiveness, which influences patients' control 
and well-being (8). Because it addresses the impact of intrusiveness on patients' HRQoL, 
defined by Devins in terms of one's ability to participate in chosen activities and achieve positive 
outcomes, Devin's Illness Intrusiveness supports CIDS-SIM, 
Complexity Theory is the final theoretical underpinning of CIDS-SIM and includes four 
assumptions (9). The theory first posits that relationships among patients and their HCPs are 
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influenced by the interactions themselves, patients' social determinants of health (SDoH), and 
their HRQoL. The second assumption of the Complexity Theory indicates that impacting one 
concept mayor may not lead to a predictable change. Related to CIDS-SIM, this assumption 
indicates the need to address not one, but multiple concepts to affect HRQoL. The third 
assumption is that new behaviors will occur as a result of relationships patients have with others. 
CIDS-SIM relates to this assumption in depicting that interactions among patients and their 
HCPs can lead to changes in patients' behaviors related to perceived symptom intrusiveness and 
their HRQoL. The final assumption of Complexity Theory addresses the blending of patients' 
symptom intrusiveness and their SDoH which can result in varying perceptions ofHRQoL (9). 
Complexity Theory supports CIDS-SIM in addressing outcomes of interactions among patients 
and their HCPs. This theory also supports the ultimate impact of this interaction on patients' 
HRQoL. 
In summary, the identified theories influenced and support the development ofCIDS-
SIM and the identification of its components first by identifying that patients' subjective 
perceptions of factors related to their chronic conditions will impact their sense of well-being. 
SMM supports CIDS-SIM in its focus· on the symptoms of chronic conditions and the effect 
symptom frequency, severity, and duration have on ones' HRQoL. Devins' research supports 
CIDS-SIM in identifying that the perception patients have of the intrusiveness of their chronic 
condition will affect their HRQoL. Finally, Complexity Theory influenced the development of 
CIDS·8IM by identifying that the outcome of the patient-HCP interaction impacts patients' 
HRQoL, all factors that impact HRQoL need to be addressed, and that SDoH and perceived 
symptom intrusiveness can have varying degrees of impact on patients' HRQoL. 
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Literature Review 
To identify concepts related to chronic symptoms and the impact on HRQoL, a 
comprehensive, computer-assisted search of the literature was conducted in the National Library 
of Medicine PubMed service (PubMed), Cumulative Index of Nursing and Allied Health 
Literature (CINAHL), PsychINFO, and PsychARTICLES electronic databases to identify 
relevant research studies limited to English and humans. In PubMed, the term chronic disease 
[MeSH] (119,862) was combined with the term symptom [All Fields] (74,563) resulting in 2,071 
abstracts. A combined search in CINAHL, PsychINFO, and PsychARTICLES using the 
keywords symptom (159,624) and chronic (178,706) resulted in 13,946 articles. This search was 
then combined with intrusiveness (714), which resulted in 20 articles. The final sample for 
review included 2091 abstracts from 1967 to 2011. No inclusion or exclusion criteria beyond 
research studies, human, and English were applied to the search so that all key terms relating to 
symptoms and/or intrusiveness in chronic conditions could be identified in the review of 
abstracts. To limit the number of terms to be included in our conceptual model similar terms 
were. then combined into a common term. 
Chronic IlIoessJDisease States - Symptom Intrusiveness Model 
The first step of the C ... T ... E structure includes naming of the conceptual model and 
identifying its concepts (6). The intent was for the name of the model to include the key concepts 
that impact patients' perception of their HRQoL; therefore, chronic illness, chronic disease, and 
symptom intrusiveness comprise the name. Through a review of the literature the key concepts 
of the model were identified and defmed (Table 2). 
Major Concepo 
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A chronic illness/disease state is one that is constantly present and long lasting (11). 
Chronic illness is defined as a patient's subjective perspective, a perspective known only to the 
patient. In contrast, chronic disease represents a health care provider's (Hep) objective 
perspective, which reflects the provider's focus on the etiology of the condition (3). An 
important factor related to chronic conditions is symptoms associated with the condition. A 
symptom is defined as a subjective indication of a change from normal well-being or appearance 
(12). Intrusiveness is the process of interfering with biopsychosocial well .. being (4). Therefore, 
to understand the intrusiveness of symptoms associated with chronic conditions, this manuscript 
discusses: (a) the interaction among patients and their HCPs, (b) the intrusiveness of patients' 
symptoms, and (c) the impact of symptom intrusiveness on patients' health-related quality of life 
(HRQoL). Despite the impact of symptom intrusiveness, the literature includes limited research 
regarding how interactions among patients and their HCPs influence patients' perceived 
symptom intrusiveness, and how symptom intrusiveness affects patients' HRQoL. 
Several of the concepts of CIDS-SIM have widely ~cepted definitions and are 
referenced in this model. Multiple definitions, each with minor variations, were noted for other 
concepts. Therefore, we have defmed these concepts, taking into consideration the previously 
defmed tenns noted in the literature. 
Observabilily of Concepts 
The second step in the formalization of a c-T -E structure is to classify concepts on the 
basis of their observability (6). We used Kaplan's concept classification schema as it refers to 
phenomena that can be directly or indirectly observed and phenomena that are theoretical which , 
can be interpreted on questionnaires (6). Concepts identified in CIDS-8IM can be directly 
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observed through auditory and visual senses and indirectly observed through patients' signs and 
symptoms. Concepts can also be observed in patients' responses to questionnaires (7). 
Relationship of Concepts 
The third step in the formalization of a C-T -E structure is to define concepts and 
relationships among concepts (6). CIDS-SIM first notes the difference between illness and 
disease. Chronic illnesses entail patients' subjective perspectives, which are unknown to anyone 
other than themselves (3). Chronic diseases entail HCPs' objective perspectives, which focus on 
the etiology of patients' conditions. Perceptions patients have of their chronic illness states are 
derived from the following: (a) their sense of self-efficacy, (b) concurrent symptoms of co-
morbid conditions, (c) their mental health, (d) stigma felt by patients due to their chronic 
symptoms, and (e) any social determinants of health impacting on patients. Patients' perceptions 
of their well-being are the basis for interactions with their HCPs. Reps formulate appraisals of 
patients' chronic disease states based upon their knowledge of the physiology of patients' 
symptoms; and the age, gender, and race/ethnicity of HCPs' and their patients (13). When 
communication, both verbal and nonverbal, is ineffective, participants in the interaction may 
form differing perceptions of patients' health and well being. If ineffective communication 
occurs, patients will often feel a lack of respect from their HCPs and develop perceptions that 
their HCPs did not attempt to understand their perspectives (13). 
The outcomes of interactions between patients and their RCPs, and perceptions each has 
of the patients' health and well being will impact on the symptom intrusiveness perceived by 
patients as depicted by the relationships noted in CrDS-SIM. Symptom intrusiveness includes: 
(a) patients' control and ability to cope with chronic symptoms, (b) symptoms patients are 
currently experiencing related to any co-morbid conditions, (c) intensity of chronic symptoms, 
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and (d) the extent to which patients adhere to' a mutually agreed upon treatment plan. The 
greater the disparity noted in appraisals of chronic conditions among patients and their HCPs, the 
greater the intrusiveness of symptoms experienced by patients. 
HRQoL is comprised of functional status, mental health, and social relations (14). The 
symptom intrusiveness experienced by patients will impact on these components of HRQoL. 
More perceived symptom intrusiveness will result in a greater negative impact on patients' 
HRQoL. This perceived impact on HRQoL will in tum negatively impact on patients' 
perceptions of their chronic illness states. This impact on HRQoL and the resulting impact on 
chronic illness states will promote a negative cyclical process involving patients' perceptions of 
their health and well being, the degree of symptom intrusiveness, and the impact on HRQoL. 
Propositions 
The fourth step in the formalization ofa C-T-E structure is to identify propositions that 
are widely accepted and therefore do not require testing (6). Assumptions related to the 
development of CIDS-SIM are discussed earlier in this manuscript. Briefly, assumptions of 
CIDS-SIM relate to the different perceptions of chronic illness and disease states, the impact.of 
patients' interactions with their H CPs, and affe~ts of their perceived symptom intrusiveness on 
their HRQoL. 
Diagram of Conceptutd Model 
The fifth and final step in the formalization of a C-T -E structure is the construction of a 
diagram of the conceptual model's concepts and propositions (6). The relationships among 
concepts of CIDS-SIM are depicted in Figure 1. The solid lines and arrows indicate the 
directional relationships among concepts. As this diagram illustrates, CIDS-SIM provides a 
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comprehensive view of the phenomenon of intrusiveness of symptoms related to chronic illness 
disease states and the impact on HRQoL. 
Discussion 
As noted previously, there has been a shift in disease burden from infectious disease to 
chronic conditions., By the year 2020, chronic conditions are expected to affect 80 million 
Americans. To treat this population effectively, HCPs must understand the effects that patient-
HCP interactions have on patients' perceptions of their symptom intrusiveness. HCPs must also 
understand and assess the impact of patients' perceived symptom intrusiveness related to their 
chronic conditions and how this affects their HRQoL. 
Theories related to chronic conditions often explore conditions as opposed to focusing on 
symptoms of the chronic conditions. CIDS-SIM provides a unique way to address chronic 
conditions by focusing on the associated symptoms, perceptions of symptom intrusiveness, the 
impact symptom intrusiveness has on HRQoL, and the effect symptom intrusiveness has on 
future patient-ReP interactions. CIDS-8IM also includes factors that contribute to the primary 
components of the model including: perceptions of self -efficacy, any current symptoms of co-
morbid conditions, mental health, perceptions of stigma, and social determinants of health. 
Communication is vital to understanding patients' perceptions of their symptom 
intrusiveness. HCPs' appraisals of patients' perceptions of their chronic conditions is included in 
this model as HCPs' appraisals impact on the outcome of interactions among patients and their 
HCPs. This vital communication is also impacted by patients' appraisals of their health status. 
Results of patient - HCP interactions affect patients' perceptions of symptom intrusiveness, 
which in turn impacts upon their HRQoL. 
Conclusion 
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CIDS-SIM identifies multiple concepts and interactions among those concepts that will 
enable RCPs to understand how patients develop perceptions of their RRQoL. CIDS-SIM will 
assist RCPs in understanding that patient-RCP interactions impact patients' perceived symptom 
intrusiveness; perceived symptom intrusiveness impacts patients' perceptions of their HRQoL, 
and HRQoL in tum impacts on further patient-HCP interactions. Our goal in developing CIDS-
SIM was to provide an illustration of factors that RCPs' must recognize and components that 
should be included in an assessment to enhance the potential for more positive patient outcomes. 
The development of CIDS·8IM is the fIrSt step in the process of developing the CID8-
81M theory. To further the development of this theory, multiple areas of CI08-8IM will require 
research. Research is needed related to the interactions between patients' and their RCPs and the 
way the outcome of this interaction impacts patients' perceived symptom intrusiveness. There is 
also a need to identify if a HRQoL assessment instrument that focuses on the impact of chronic 
symptoms is available to enhance HCPs' objective assessment. If an instrument is not identified, 
the next step in this process will be to develop an instrument to assess the degree to which 
patients' chronic symptoms impact RRQoL. The development of this instrument will further 
elucidate the relationships among the concepts depicted in CID8-8IM. 
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Table 1 Theoretical Foundation for Concepts of CIDS-SIM 
Theories that underpinCIDS .. SIM 
Common Sense Model (CSM) 
Symptom Management Model (SMM) 
Illness Intrusiveness 
Complexity Theory 
Table 2 Definition of Concepts 
Chronic Illness States 
Self-Efficacy 
Symptoms of Co-morbid Illnesses 
Mental Health 
Stigma 
Social Determinants of Health 
Chronic Disease States 
HCP Knowledge of Patient Symptoms 
HCP Characteristics in relation to 
Patient characteristics: Age, Gender, 
Race/ Ethni . 
<{ 
.... 1/· Tb.eorY~()llcftPts used to developCIDS:SIM 
Patients' subjective perspective 
Symptom experience, impact on HRQoL 
Illness intrusiveness as a basic determinant of the 
psychosocial impact of chronic diseases 
Patient - HCP interaction, impact on HRQoL 
The subjective perspective of the patient that is 
unknown to other than the atient. 
A patient's belief in his or her ability to yield an 
identified degree of functioning that can influence 
cognitive, motivational, affective and selection 
cesses 15 
Two or more biopsychosocial disease processes that 
co-exist with an initial disease process, which may 
. 'ent's health outcomes. 
The functioning of the mind related to thinking, 
behavior and a state of well b . 
The verbal or non-verbal communication that occurs 
among persons where one person impresses upon 
another son the label of social tabi 
Biopsychosocial facets related to age, gender, 
race/ethnicity, inborn characteristics, environment, 
education, disability, socioeconomic status, social 
support, material resources, access to health services, 
and social networks. 
The objective perspective of the HCP that looks at 
the etiolo of the condition. 
A HCP's objective appraisal is impacted by his or 
her knowled of the 13 . 
A HCP's characteristics affect his or her perception 
of the patient's health (16). 
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Patient - Hep Interactions Any verbal and non-verbal communication or 
exchange that occurs between a patient and his or 
her HCP (17). 
Symptom Intrusiveness A subjective or objective change from normal, 
which interferes with patients' biopsychosocial well 
being. 
Symptom Control A patient's coping strategy to balance his or her 
perceived risk(s) against the emotional reaction( s) to 
the health threat (18). 
Symptom Occurring Simultaneously Co-existing symptoms or co-morbid symptoms are 
with Symptoms of Co-morbid defined as the presence of concurrent chronic 
Illnesses symptoms (19). 
Symptom Severity The level of intensity that a patient experiences 
related to i3y l11VtOms of his or her chronic illness. 
Treatment Adherence The extent to which ~ patient follows a previously 
mutually agreed upon treatment plan (4). 
Health-Related QuaHty of Life A patient's sense of well being determined by his or 
her subjective evaluation of current functional ability 
as compared to his or her expectations 120). 
Functional Status The ability that a patie,t ~ to perform self-care and 
, participate in physical activities (21). 
Mental Health The functioning of the mind related to thinking, 
behavioral and a state of well being (4). 
Social Relations An interaction or relationship between two or more 
individuals or gri)UpS~ 
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Background: The number of patients surviving with multiple chronic conditions is increasing. 
Therefore, health care providers' (HCPs') ability to comprehensively assess and effectively treat 
patients with chronic conditions is vital, especially since many with chronic conditions exhibit 
associated symptoms or treatment side effects that significantly impact their health-related 
quality of life (HRQoL). To enhance the development of effective treatment plans, RCPs must 
take into account both their objective perspectives regarding their patients' conditions and 
patients' subjective perspective about symptom intrusiveness - the degree to which symptoms or 
treatment side effects intrude on their HRQoL. At present, the literature contains no description 
of a subjective HRQoL assessment instrument that focuses on symptoms and treatment side 
effects; thus, the development of such tool is necessary and will add to the body of knowledge 
related to HRQoL assessment. 
Objective: Our objective was to develop an HRQoL assessment instrument that focuses on the 
subjective symptoms and treatment side effects of chronic conditions and their impact on 
HRQoL. This novel instrument is designed to provide results related to patients' subjective 
assessments that can augment HCPs' objective assessments by identifying areas related to 
HRQoL that should be addressed in treatment plans. The inclusion of subjective assessments will 
aid in developing more effective treatment plans thus improving the potential for positive patient 
outcomes. 
Result: The Symptom Intrusiveness Rating Scale (SyIRS) was developed. An assessment 
instrument that focuses on the impact of subjective symptoms and treatment side effects, this 
scale allows respondents to indicate on a one-to-five Likert scale the degree to which they 
perceive their symptoms or treatment side effects are intruding on their HRQoL. HRQoL is 
defined in terms of the domains functional status, social relations, and mental health with five 
subcomponents in each domain. 
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Keywords: Symptom Intrusiveness Rating Scale, health-related quality of life, assessment, 
instrument, subjective symptoms, subjective side effects, symptom intrusiveness, treatment side 
effects intrusiveness, chronic conditions 
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Initial Development of the Symptom Intrusiveness Rating Seale (SyIRS) 
Improvements in health care and changes in health care policy have resulted in an 
increasing number of patients surviving chronic conditions that were previously fatal (1). A~ a 
result of this increasing survival rate, a growing percentage of patients present to their health care 
providers (HCPs) with multiple co-morbid conditions, thus shifting the disease burden in the 
United States from infectious to chronic diseases (2). Studies have confirmed this shift, in 
showing $at patients with chronic conditions account for 75% of health care expenditures 
annually (2, 3). By the year 2020, it is estimated that 80 million Americans will have multiple 
j 
chronic conditions (4). 
The perspectives HCPs develop of their patients' well-being are objective and based 
primarily on the results of laboratory tests, radiologic studies, and physical exams. HCPs' often 
focus on identifying the etiology of symptoms or treatment side effects and developing treatment 
plans aimed at a cure (5). However, a cure is often not possible with chronic conditions; 
therefore, the focus of treatment in this population needs to include effective management of 
symptoms. HCPs are challenged to assess chronic conditions by integrating their objective 
perspectives with the subjective perspectives of patients experiencing symptoms or treatment 
side effects associated with chronic conditions. A review of the literature identified the lack of a 
subjective HRQoL assessment instrwnent that focuses on the impact of chronic symptoms and 
treatment side effects from the patients' perspectives; therefore, the focus or our research Was to 
identify a process by which HRQoL could be subjectively as~ssed in this population. 
In research, as investigators attempt to quantify a phenomenon, a method of measurement 
is a vital component. However, an instrument is not always available that assesses the focus of 
researchers' work. In such a case researchers find it necessary to develop a new instrument or 
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revise an existing instrument that will adequately assess the focus of a study. The process of 
instrument development or revision involves clearly identifying what is to be measured, 
generating a pool of items, formatting the instrument, seeking expert review of the relevancy of 
instrument items, and evaluating the validity and reliability of the newly developed instrument 
(6). Our goal was to assess symptom intrusiveness, the degree to which patients determine that 
symptoms or treatment side effects of chronic conditions impact on their health related quality of 
life (HRQoL); therefore, to obtain relevant data, following this process of instrument 
development was crucial. 
The results of a comprehensive literature search indicated the lack of a subjective 
HRQoL assessment instrument that focused on the intrusiveness of symptoms or treatment side 
effects associated with chronic conditions. We thus identified the need for an instrument that 
could be adapted to focus on symptoms and treatment side effects. Permission was received to 
modify the Illness Intrusiveness Rating Scale (7) with the resulting instrument identified as the 
Symptom Intrusiveness Rating Scale (SyIRS) (Appendix A). 
This paper describes the initial phases toward the development of the SyIRS instrument, 
designed to subjectively assess the intrusiveness of symptoms or treatment side effects associated 
with chronic conditions that impact patients' HRQoL. This instrument will assist HCPs in 
identifying areas of need with the goal of improving HRQoL. SyIRS will also enable researchers 
to assess the impact of the symptoms and treatment side effects of chronic conditions on HRQoL 
as well as the outcomes of interventions. Validity and reliability studies, the final phase of 
instrument development, are currently being developed and conducted in populations with 
specific chronic symptoms and treatment side effects. 
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Conceptual Framework 
We conducted a literature review of theoretical studies related to symptoms, finding only 
one theory that addressed symptom experiences related to chronic conditions (8). Dfthe theories 
( reviewed, no theory addressed the intrusiveness of symptoms related to chronic conditions. To 
address this noted gap in literature, we developed the Chronic IllnesslDisease State - Symptom 
Intrusiveness Model (CIOS-SIM) (Appendix B) (9). This model has been adapted with 
permission from Leventhal's Common.Sense Model (10) and Spirig's Symptom Management 
Model (11). The purpose of CIOS-SIM is to illustrate the relationships among patients' 
appraisals. of their chronic conditions, H CPs' assessments of patients' well-being, patients' 
perceived symptom or treatment side effect intrusiveness, and the impact of that perception on 
their HRQoL. 
CIOS-SIM fIrSt identifies the difference between disease and illness (9). Oisease is an 
HCP's objective perspective, which focuses on the etiology of a condition. Illness is a patient's 
subjective perspective and is unknown to anyone other than the patient (12). The perspective a 
patient develops of one's own chronic condition is derived from the following: (a) one's sense of 
self-efficacy , (b) concurrent symptoms or treatment side effects of co-morbid conditions, (c) 
one's mental health, (d) stigma felt by a patient due to one's symptoms or treatment side effects, 
and (e) the social determinants of health impacting on a patient. The patient's perspective of 
one's own well being is the basis for any interaction with one's HCP (13). The appraisal a HCP 
formulates of a patient's chronic condition is based on his or her knowledge of the ' 
pathophysiology of a patient's symptom or treatment side effect, as well as the differences and/or 
similarities in age, gender, and/or race/ethnicity between an HCP and the patient. When 
communication, both verbal and nonverbal, is ineffective, an HCP and patient can develop 
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different perceptions of a patient's health and well being, and a patient will often feel a lack of 
respect from the HCP, developing a perception that the HCP did not attempt to understand the 
patient' s perspective (13). 
The symptom or treatment side effect· intrusiveness experienced by a patient will impact 
on one's HRQoL, which is comprised of a patient's functional status, social relations, and mental 
health (14). The greater the symptom or treatment side effect intrusiveness perceived by a 
patient, the greater the negatively perceived impact on HRQoL. This perceived impact on 
HRQoL will in turn negatively impact on a patient's perception of one's chronic condition. This 
impact on HRQoL and the resulting impact on a chronic condition will promote a negative 
cyclical process involving a patient's perception of one's health and well being, the degree of 
symptom or treatment side effect intrusiveness, and the impact on HRQoL (14). 
Definitions of Terms 
The terms symptom and side effect were defined to determine the appropriateness of 
including both in the same assessment instrument related to the impact of these consequences of 
chronic conditions on a patient's HRQoL. The term symptom is defmed as a mental and/or 
physical condition change that develops from and accompanies an illness and is perceptible to 
the patient who experiences it (15). A side effect is defined as a consequence of a treatment that 
results in an unintended secondary effect that is perceptible to the patient who experiences a 
change in one's biopsychosocial status (15). A side effect can be perceived as a symptomatic 
change in one's status as it accompanies the primary condition. Since a side effect can be 
perceived as a symptomatic change in a patient's biopsychosocial status, a side effect can be 
considered a symptom and thus be included in a subjective assessment of symptoms. 
Literature Review 
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A comprehensive, computer-assisted search of the literature was conducted in the Ovid 
Medline, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsycINFO, and 
PsycARTICLES electronic databases to identify relevant assessment instruments that evaluate 
the impact of symptoms and treatment side effects on patients' HRQoL. The review was limited 
to English, humans, and research studies included in the electronic databases from inception of 
the databases through January 2012. In Ovid Medline, the MeSH term health-related quality of 
life (14371) was combined with questionnaires (216834) resulting in 5818 abstracts. The 
resulting abstracts were combined with the MeSH tenn symptom (affective and behavioral) 
(9440), keyword side effect (94895), and keyword intrusiveness (339) which resulted in no 
abstracts for review. 
Ina combined search in CINAHL, PsycINFO, and PsycARTICLES, the MeSH term 
health-related quality of life (9033) was combined with questionnaires (198418), resulting in 
2905 abstracts. The resulting abstracts were combined with the MeSH term symptom (17294) 
and the keyword side effects (30203), which resulted in 556 abstracts for symptoms and 34 
abstracts for side effects. When the combined search of health-related quality of life and 
questionnaires (2905) was combined with symptoms (556), side effects (34), and the keyword 
intrusiveness (831) a total of 15 abstracts were identified. These abstracts were reviewed for 
questionnaires that assessed the intrusiveness of symptoms and treatment side effects on 
HRQoL. No questionnaires were identified that met this criterion; therefore, a gap was noted in 
the literature. 
Instrument Development 
The development of an instrument is a multi-phase process (16). The first phase of 
development is to determine the need for an instrument to measure an identified construct. Once 
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a need is identified, it is prudent to determine if an existing instrument can be used or amended 
to address the current need as the dev~elopment of a new instrument requires significant time, 
effort, and expertise. If an instrument is identified, pennission to use or adapt the instrument 
should be obtained from the researcher. The process then involves developing the item pool, 
determining the fonnat, and finally testing the reliability and validity of the new instrument (16). 
The initial phases of the development ofSyIRS are discussed here. 
Phase 1: Determine need 
The symptoms and the treatment side effects of chronic conditions are often assessed 
only from the objective perspectives of the HCPs. An assessment that is limited by the 
perspective from which the evaluation is conducted can lead to an ineffective 
treatment/management plan. Research has indicated that an objective assessment alone does not 
accurately reflect the complexity of the impact of symptoms or treatment side effects on patients' 
HRQoL (17). A comprehensive assessment of chronic· conditions including associated symptoms 
and treatment side effects must include both the objective perspectives of the HCPs as well as the 
subjective perspectives of patients afflicted with chronic conditions. Therefore, the goal was to 
develop an instrument that would subjectively assess the degree to which symptoms or treatment 
side effects impact on patients' HRQoL. This assessment is intended to enhance the objective 
assessments completed by HCPs thus enhancing the ability of HCPs to develop more effective 
management/treatment plans. 
A review of the literature identified several instruments that assess the impact chronic 
conditions have on patients' HRQoL .. Our work is based on the assertion that patients with 
symptoms or treatment side effects associated with their chronic conditions will assess the 
impact the condition has on their HRQoL differently than patients not experiencing related 
symptoms or treatment side effects. The impact patients note related to their functional status, 
social relations, and/or mental health is more often associated with the symptoms or treatment 
side effects of the chronic conditions. Therefore, a need was identified· for an instrument that 
specifically assesses the impact of symptoms or treatment side effects on patients' HRQoL. 
Phase 2: Explore available instruments 
62 
A literature review, as noted previously, indicated there were no instruments in which the 
intrusiveness of symptoms or treatment side effects was the basis for the assessment of HRQoL. 
Condition-specific assessment questionnaires as well as generic questionnaires that assessed 
HRQoL were found; however, condition-specific instruments were not adaptable for use with all 
chronic conditions and associated symptoms or treatment side effects. Therefore, they were not 
appropriate for use with multiple chronic conditions. The generic HRQoL questionnaires 
identified, the SF-36 (18) and the SF-36v2 (19), did not address the intrusiveness of symptoms or 
treatment .side effects. Therefore, a HRQoL instrument to assess the impact of symptoms and 
treatment side effects on patients' HRQoL was needed. 
Phase 3: Adapt Illness Intrusiveness Rating Scale 
The Illness Intrusiveness Rating Scale (IIRS) (20) was found during a literature review of 
the term intrusiveness. This psychometrically tested instrument was suitably structured; however, 
the IIRS, which explores the intrusiveness of an illness, does not address the intrusiveness of 
symptoms or treatment side effects of chronic conditions. Permission was obtained from Dr. 
Gerald Devins to adapt IIRS to focus on the intrusiveness of symptoms and treatment side 




A second literature review was conducted to identify the domains of HRQoL. The 
dimensions ofHRQoL most often noted in the literature relate to physical, social, cognitive, 
sexual, and psychological functioning as well as productivity, sleep disturbances, and bodily 
symptoms (21). Researchers have merged the noted dimensions, indicating that HRQoL is 
comprised ofa person's physical, psychological, social, and spiritual well being (22). After 
review of the literature, HRQoL is defined in the development ofSyIRS as: (a) functional status 
- ability to perform activities of daily living, (b) social relations - the relationships between 
patients and their social world, and (c) mental health - level of cognitive or emotional well 
being. 
Item Development 
Once the three domains of HRQoL were identified and defined, further review of the 
literature was conducted to identify aspects that define each domain. Items that were developed 
to comprise the functional status domain included activities that most patients are involved in on 
a daily basis in caring for themselves. The social relations domain was determined to be related 
to interactions patients generally have with family and/or friends. The mental health domain 
includes items related to the ability to cope with nonnal stresses, contributions to the community, 
and patients' perceptions of their own abilities. As items were developed and revised, we 
continuously confirmed that SyIRS did not veer from the intent of the assessment instrument by 
confirming in the current literature that all items developed related to one of the defined domains 
ofHRQoL. 
In the development of scale items, consideration was also given to the number of items 
and the length of time it would take to complete the assessment (6). Items were all written as 
positive declarative statements for consistency. 
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!lesponse Scale 
In -1984, O. D. Duncan expanded upon the definition of measurement, numbers applied to 
objects or events according to distinct rules, by adding the component that the numbers are to be 
assigned in such as way as to be compatible with varying degrees of quality (6). The Likert 
Scale, a commonly used measurement, is used for the response format of SyIRS to identify the 
degree to which patients believe their symptoms and treatment side effects associated .with 
chronic conditions impact their HRQoL. The statements included in SyIRS are followed by 
response options that reflect equal distance between responses (6) and which indicate the 
frequency patients assess that their symptoms or treatment side effects are impacting on their 
HRQoL. The response options on SyIRS are based on a 5-point Likert scale indicating never, 
occasionally, about half the time, frequently, and all the time which is similar to the 7 -point 
Likert scale used on IIRS. 
Phase 4: Plan/or testing SylRS 
In developing a generic instrument, we are aware of the need to conduct psychometric 
testing of SyIRS. To confirm that SyIRS assesses patients' HRQoL, the following psychometric 
tests are currently being conducted; ( a) content validity, requesting input from experts on the 
relevancy of the items on SyIRS, (b) cognitive pretesting, interviewing a limited number of 
patients to confirm that subjects will interpret the items on SyIRS as intended, (c) face validity, 
,_ asking the respondents ifSyIRS appears to be assessing their HRQoL, (d) criterion validity, 
correlating the results ofSyIRS with an instrument that has had validity previously confirmed, 
(e) internal consistency, assessing if all the items on SyIRS assess HRQoL, and (f) test retest, 




SyIRS has been developed to provide a subjective assessment instrument to quantify the 
intrusiveness of symptoms and treatment side effects on HRQoL from the perspectives of 
patients afl1icted with chronic conditions. The development ofSyIRS addresses the need for a 
subjective instrument that is intended to augment HCPs' objective evaluations, thus enabling the 
development of comprehensive assessments for patients with chronic conditions. This growing 
population is in need of comprehensive assessments to enhance the ability of HCPs to develop 
effective treatment plans, which will improve the potential for patients to achieve the HRQoL 
which they define as acceptable for themselves. 
In future work, psychometric testing of SyIRS is necessary with a large sample size and 
among patient with diverse chronic conditions experiencing varied symptoms and treatment side 
effects. Once psychometrically tested, the subjective results obtained from SyIRS are intended to 
enhance HCPs' objective assessments of patients experiencing symptoms and treatment side 
effects associated with chronic conditions. 
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Appendix A 
SYMPTOM INTRUSIVENESS RATING SCALE (SyIRS) 
CIRCLE THE NUMBER THAT DESCRIBES HOW MUCH YOUR SYMPTOM OF AFFECTS THE ITEM LISTED. 
FUNCTIONAL STATUS· 
• Ability to care for yourself 
(bathing, dressing, eating) 
• Ability to maintain employment 
• Ability to care for your home 
(light cleaning, laundry, cooking) 
• Ability to complete errands 
(shopping, post office) 
• Ability to drive a car or use 
public transportation 
SOCIAL RELATIONS· 
• Ability to visit with family or 
friends 
• Ability to attend activities outside 
your home 
(church, social activities, etc.) 
• Ability to participate in pleasurable 
activities (painting, sports, knitting etc.) 
• Ability to be affectionate (hugs, 
intimate relations etc.) with those you 
would like to be 
affectionate with 

















occasionally about half the time frequently always 
\. ) \.. ) \. J L- J 
+ + + + 
2 3 4 5 
2 3 4 5 
2 3 4 5 
2 3 4 5 
2 3 4 5 
occasionally about half the time frequently always 
\. ) \.. ) \. J \ ) 
+ + + + 
2 3 4 5 
2 3 4 5 
2 3 4 5 
2 3 4 5 
70 
• Ability to ask friend or family 1 2 3 4 5 
member for assistance 
MENTAL HEALTH· never oecasionaUy about baH the time frequently always 
l ---.J \. ) "- ) \ J L- J 
~ ~ ~ ~ ~ 
• Ability to enjoy pleasurable 1 2 3 4 5 
activities 
• Ability to be happy 1 2 3 4 5 
• Ability to manage your outward 1 2 3 4 5 
feelings (crying, anger outbursts, etc.) 
• Ability to think, concentrate, or 1 2 3 4 5 
make decisions 
• Ability to have feelings of 1 2 3 4 5 
self-worth 
* Section heading will not be included in survey given to participants. Items will be randomly ordered. 
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Abstract 
Purpose: The purpose of this study was to determine the feasibility of administering the 
Symptom Intrusiveness Rating Scale (SyIRS) to assess the health-related quality of life 
(HRQoL)·ofpatients admitted to an acute care hospital who were experiencing chronic wound 
pain. In this study, tests were also conducted to determine if SyIRS is a valid and reliable 
instrument. 
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Design: The study was designed as a feasibility pilot study with respondents recruited as a 
convenience sample from individuals admitted to an urban 500-bed acute care hospital. 
Method: The study included 4 phases. The first phase included completion and analysis of 
cognitive pretesting of Sy IRS among 10 participants. In the second phase, content expert review 
regarding the relevance of SyIRS items was obtained and analyzed. The third phase consisted of 
the administration of SyIRS and the SF-36v2, and in the fourth and final phase validity and 
reliability testing were completed and the results analyzed. 
Results: Cognitive pretesting indicated that respondents comprehend the items on SyIRS as 
intended. Content expert review confirmed the validity ofSyIRS with an S-CVI/Ave of 0.90. 
Correlation analysis between the results of SyIRS and SF-36v2 indicated strong correlation with 
a coefficient of .917 and a p-value of .000. Retest of SyIRS conducted 2 to 4 days after the initial 
test confirm reliability with a correlation coefficient range of -.460 to -.560 and a p-value of .000 
to .001. Results of this study indicated that conducting retest of Sy IRS to confIrm reliability 2 to 
4 weeks after the initial survey completion is not a feasible in this population. Exploratory 
regression analysis did not identify any variables as having predictive value related to the SyIRS 
score. 
Conclusions: SyIRS total and sub scores correlated higblywith those of the SF-36v2, a 
psychometrically tested HRQoL instrument. These findings indicate that the SyIRS instrument 
can effectively assess the HRQoL of patients experiencing chronic wound pain. 
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A Feasibility Pilot Study of the Symptom Intrusiveness Rating Scale: 
Assessing Patients with Chronic Wound Pain 
Pain has been shown to be the factor with the greatest negative impact on health-related 
quality ofHfe (HRQoL) yet this impact is often not assessed by health care providers (HCP) 
when evaluating patients experiencing chronic wound pain (1-3). HCPs most often use the 
analog or visual pain measurement scales to assess patients' pain. These instruments are 
appropriate in determining the intensity of chronic wound pain; however, these scales do not 
address how chronic wound pain impacts patients' HRQoL, defined in this study as functional 
status, social relations, and mental health. Without an assessment of chronic wound pain that 
includes both the HCPs' objective assessments and patients' subjective assessments of the 
impact of chronic wound pain on their HRQoL, a cycle of unfavorable biopsychosocial outcomes 
may ensue. Therefore, a thorough patient-centered assessment of chronic wound pain, including 
the impact on patients' HRQoL, is vital to enhance the development of an effective chronic 
wound pain treatment plan. 
This study explored the use of the Symptom Intrusiveness Rating Scale (SyIRS), a novel 
subjective instrument that focuses on the impact of chronic symptoms, as a method to assess the 
impact chronic wound pain has on HRQoL (Appendix A). SyIRS is intended to augment HCPs' 
objective assessments of chronic symptoms thus providing HCPs with a comprehensive 
assessment on which to base the development of their treatment plans. 
To substantiate the use ofSyIRS, it is necessary to detennine ifSyIRS reliably and 
accurately identifies the impact chronic symptoms have on HRQoL. Therefore, the research 
questions that guided this study are: 
1. Is the Symptom Intrusiveness Rating Scale a valid and reliable instrument to assess 
the impact chronic wound pain has on patients' HRQoL? 
2. Is the design utilized in this study an effective method to assess the validity and 
reliability of the SyIRS? 
Background 
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Nearly half of all Americans seek medical care each year due to pain (4). In the United 
States, health care costs and lost productivity related to pain have been estimated to be $61.2 
billion annually (5). In addition to being costly, pain is a sensation people fear and which can 
cause great distress and disability. Both acute and chronic pain have been shown to be factors 
with the greatest negative impact on health related quality of life (HRQoL) (1-3) affecting 
functional status and well-being (6). A more specific type of pain, chronic wound pain, 
significantly impacts patients experiencing it (7). Studies have shown that nearly 80% of people 
with chronic wounds experience pain either intermittently, continuously, or during procedures, 
such as debridement and/or dressing changes (7). Chronic wound pain significantly impacts 
peoples' HRQoL including functional status, social relations, and mental health (8). Although 
pain is a symptom that has significant impact on people, it is often misunderstood, under-
assessed and under-treated (9). 
Defmition of terms 
Pain 
The most widely accepted definition of pain was posited by the International Association 
for the Study of Pain (IASP) in 1994. The IASP defined pain as "an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage, or described in terms of 
such damage" (10) p. 210. The IASP and others who have extensively studied the pain 
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phenomenon also agree that pain is subjective (7, 11, 12). The sUbjective perception people have 
of their pain is affected by previous experiences, emotional states, mental states, and cultural 
background (13-15). 
Chronic wound pain 
Pain that is associated with a chronic wound is either an intermittent or persistent 
symptom that is often in the background and exists at rest and between procedures (16). An 
estimated 80% of people with chronic wounds experience persistent pain with 50% of those 
people rating the pain as moderate or the worst pain they have experienced (16-18). This 
persistent pain often has no specific trigger (16). Franks and Moffat assessed the impact of 
clinical and social factors on a person's HRQoL and found that as the duration of a wound 
increases so does the reported incidence of wound pain. This phenomenon is explained by 
repeated injury and nerve damage (19). 
Health-related qutllity of life 
HRQoL has been dermed in numerous ways, leading, in part; to the difficulty researchers 
and clinicians have had in assessing it (20). Within the framework of medicine, HRQoL has 
been defined as quality of life (QoL) (21). In this definition, two components comprise HRQoL. 
The first component, health, is defined as the state of absolute physical, mental, and social well-
being. The second component, QoL, is defined as the sense of satisfaction people experience in 
various aspects of their life and the ability to participate in activities they choose within family, 
work, and social environments (21). HRQoL has also been defined as a subjective 
multidim~nsional experience that is a summation of the positive and negative qualities that 
illustrate peoples' life (20). Researchers have noted the lack of distinction in derming HRQoL 
between the determinants or predictors and the dimensions or attributes. This lack of division 
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has led to confusion related to the conceptual and operational definitions of HRQoL. As a result, 
researchers strive to identify those attributes that are most salient to people with a condition 
impacting their HRQoL (20). 
HRQoL dimensions 
The dimensions of HRQoL most often noted in the literature relate to physical, social, 
cognitive, sexual, and psychological functioning as well as productivity, sleep disturbances, and 
bodily symptoms (21). Other researchers have merged the noted dimensions indicating that 
HRQoL is comprised of peoples' physical, psychological, social, and spiritual well·being (20). 
After a comprehensive review of the literature, HRQoL is defined in this study as functional 
status, social relations, and mental health. The spiritual dimension of HRQoL noted in the 
literature is a complex, often abstract dimension and beyond the scope of this study. 
Assessment 
Chronic wound pain 
A comprehensive and consistently completed assessment of chronic wound pain is the 
foundation of an effective chronic wound pain management/treatment plan (1). Research related 
to chronic wound pain assessment, although limited, has indicated that focusing solely on 
determining pain intensity, as many pain assessments do, does not accurately reflect the 
complexity of the impact of the pain (22). Therefore, a more comprehensive assessment is 
needed to fully understand the effects of chronic wound pain. 
Health-related quality of life 
An assessment of patients' HRQoL provides information regarding any subjective 
adverse effects a medical condition may have (21). An assessment ofHRQoL is one approach 
that appraises the illness experience from the perspective of patients. Vetter (2007) has defined 
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three categories ofHRQoL assessment instruments including: (a) generic (b) condition-specific 
measures, and (c) preference-based measures. Generic measures assess the continuum between 
well-being and death by providing a general review of HRQoL.. These measures can be used in a 
variety of medical settings and the reported scores can be used to expand upon the objective 
signs and symptom of the condition noted by the RCP. Condition-~pecific measures are 
generally utilized to determine clinically significant responses to treatment or the progression of 
the condition. A measure that is condition specific will identify small incremental changes in the 
domains being measured. Preference-based measures expand on the descriptive nature of 
generic and condition-specific measures by incorporating a person's opinion concerning the 
desirability of a particular health state from the person's perspective (21). 
Symptom Intrusiveness Rating Scale 
Patients with chronic symptoms will often assess the impact of the condition on their 
RRQoL differently than patients without related symptoms. A comprehensive review of the 
literature identified the lack of a subjective assessment instrument that focused on the symptoms 
of a chronic condition and the impact the symptoms have on HRQoL. SyIRS, developed to 
address this gap, was adapted with permission from the Illness Intrusiveness Rating Scale (IIRS), 
a subjective assessment instrument developed· by Dr. Gerald Devins (23) that focuses on the 
impact of a condition. SyIRS was developed to specifically assess the impact chronic symptoms 
have on HRQoL from the perspective of the people experiencing the symptoms. The results of 
SyIRS are intended to augment Reps' objective assessments with the subjective perspectives of 
patients experiencing the symptoms .. 
Methodology 
Institutional Review Board 
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Prior to beginning this study, approval was obtained from the Institutional Review Board 
(IRB) of the university where the principal investigator (PI) is a student. Approval was also 
obtained from the IRB at the acute care facility where this study was conducted. 
Study Design 
This study was designed as a feasibility pilot study to assess the validity and reliability of 
SyIRS among people experiencing chronic wound pain. The study involved the self-
administration of two surveys, SyIRS and the SF-36v2twice within 2 to 4 days. 
Variables 
The independent variables (IV) in this study include age, gender, race/ethnicity, 
employment status, educational level, marital status, and other people in household. The 
dependent variables (DV) are the scores obtained on the physical and mental subscales on SyIRS 
and SF-36v2. 
Setting/Sample Siz.e 
Fifty respondents were recruited as a convenience sample from individuals admitted to an 
urban 500-bed acute care facility in a mid-south city. Respondents were enrolled over a period of 
3 months. For the continuous outcome measures, SyIRS and SF-36v2, with 50 participants the 
95% confidence interval estimate of the correlation between the scales had precision of 
+ 0.29. 
InclusionlExclusion criteria 
Inclusion criteria were: (a) 21 years of age and older, (b) a numeric wound pain intensity 
rating of2 or greater, (c) wound reported for at least 4 weeks, and (d) ability to complete a self-
administered survey. Exclusion criteria included: (a) end-of-life as identified by the HCP, (b) 
cognitive impairment including inability to comprehend instructions or survey content, and (c) 




The first phase of the study was to conduct cognitive pretesting of SyIRS to critically 
evaluate if a target population comprehends and processes each item on the survey as intended 
by the researcher (24). SyIRS is intended to assess people experiencing symptoms of a chronic 
condition; therefore, subjects who were experiencing varied chronic symptoms, were recruited. 
Participants were interviewed one-on-one at the facility where the entire study was conducted. 
An interview manual, developed prior to testing, was used to promote consistency during the 
cognitive pretesting. The goal of cognitive pretesting was to elicit information relevant to the 
participants' interpretation of the SyIRS items (24). Since the participants in cognitive pretesting 
are not intended to be representative of the larger population, fewer participants were recruited 
(N=10) for this phase of the study then were recruited for the next phase (25, 26). 
The PI conducted cognitive pretesting utilizing concurrent verbal probing. The process 
involved first asking the survey questions followed by probes. The PI also asked unscripted 
"emergent" probes and/or neutral probes as a follow up for unanticipated problems and further 
clarification. The PI was aware of potential bias and avoided asking any leading questions that 
could have inadvertently guided a respondent's answer. 
Surveys and survey completion 
The surveys utilized in this study were SyIRS and SF-36v2. SyIRS is comprised of 15 
items, which are randomly ordered for administration and reflect activities and mental states 
related to the three components ofHRQoL: functional status, social relations, and mental health. 
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In this study chronic wound pain was indicated in the instructions as the chronic symptom being 
assessed. The responses on the SyIRS survey are based on a Likert Scale indicating; 1- never, 2 -
occasionally, 3 - about half the time, 4 - frequently, 5 - always. The SyIRS total score range is 
15 to 75. The range of scores in the physical sub scale is 8 to 40 and in the mental subscale the 
range of scores is 7 to 35. 
The SF-36v2 is a psychometrically tested HRQoL assessment instrument (27). Previous 
studies have confirmed content, concurrent, criterion, construct, and predictive validity of SF -
36v2. SF-36-v2 has been noted to correlate with the results of225 other measures. Reliability 
coefficients, using both internal consistency and test-retest, have exceeded the recommended 
level of 0.70. Reliability estimates were consistent in 200 reported studies and 30 test-retest 
studies (27). 
SF-36v2 is an II-item questionnaire that measures the overall health status, functional 
status, and HRQoL of individuals or groups (28). The SF-36v2 questionnaire utilizes eight 
domains: physical functioning, role-physical, bodily pain, general health, vitality, social 
functioning, role-emotional and mental health. Responses on the SF-36v2 are based on the 
Likert scale with varying responses and are scored utilizing norm-based scoring (28). 
The preferred time between the completions of surveys when conducting test re-test 
reliabilitY testing is 2 to 4 weeks (29) .. The average length of stay in the acute care facility where 
the study was completed is 5.1 days. There was concern in developing the study, that patients 
discharged prior to the retest at 2 weeks would not be compliant in completing and returning the 
surveys via the mail. Although the time frame between administrations is less than 
recommended, to ensure the availability of test -retest data, patients were asked to complete the 
survey the second time 2 to 4 days after the initial administration while still an in-patient;. To 
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determine if it would be feasible to complete the re-test portion of reliability testing in the 
recommended 2 to 4 week time frame, after patients are discharged, respondents who were 
admitted to the facility for less than 2 weeks were asked to first complete retest 2 to 4 days after 
initial administration and then were also given the surveys upon discharge with a self-addressed 
stamped envelope. The patients were asked to complete the survey during the week noted on the 
survey and to return the survey to the PI via the mail system. The return rate for completion of 
the survey 2 weeks after the initial administration was calculated. 
Data analysis 
Internal consistency was assessed using Cronbach's alpha. Reliability was assessed using 
Pearson's correlation coefficient for Sy IRS total score at first and second administration. Further, 
the relationship between SyIRS and SF-36v2 was examined using Pearson's correlation 
coefficient. 
In addition, exploratory regression was conducted to determine if the independent 
variables; age, gender, race/ethnicity, employment status, education level, marital status, or 
people in household were predictive of symptom intrusiveness. Individual regression modeling 
was used with SyIRS total score as the dependent variable and each of the demographic variables 
as independent variables. Subsequently, exploratory forward regression was conducted to 
determine which independent variables were predictors of the results of SyIRS accounting for 
other variables in the model. Next, models were developed using SyIRS as nv, the SF-36v2 
physical and mental sub scale scores as the first independent variable of interest and the 
individual demographic variables as adjustment variables. Finally, SF-36v2 physical and mental 
subscale scores were added to the model including all IV s to examine the relationship of the 




Fifty patients were approached to participate in the study. All 50 signed an informed 
consent form agreeing to participate, met inclusion and exclusion criteria, and were enrolled in 
the study. Table 1 indicates the demographic characteristics of the respondents. One respondent 
died 36 hours after completion of the second survey administration. The death was reported to 
the university and facility IRBs. Each IRB determined the death to be unrelated to the study. 
Cognitive pretesting 
The cognitive pretesting respondents (N=10) ranged in age from 36 to 74; four were male 
and six were female. Each respondent was experiencing symptoms related to a chronic condition. 
The results of cognitive pretesting indicated that the items on SyIRS were interpreted by the 
respondents as was intended; therefore, no changes in the items were made. 
Content validity 
Two experts in the field of HRQoL were asked to review the statements included in 
SyIRS. The review by experts included rating each item as 1 .. not relevant, 2 - somewhat 
relevant, 3 .. quite relevant or 4 .. highly relevant in relation to HRQoL. After the reviews were 
completed, the scale-level content validity index average (S-CVII Ave) was calculated as 0.90 
indicating excellent content validity (30). Therefore, all items that comprise SyIRS were retained 
Reliability - Internal consistency and Correlation coefficients 
A Cronbach's alpha of .904 indicated high internal consistency suggesting that the items 
included in SyIRS all measure HRQoL. 
SyIRS total score at initial administration was strongly positively correlated with the 
SyIRS total score at second administration 2 to 4 days later (r=.92, p < .005). The physical and 
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mental subscale scores of SyIRS and SF-36v2 showed a moderate negative correlation on the 
initial completion (r= -.56, p < .005 and r= -.46, p < .001 respectively) versus the second 
completion 2 to 4 days later (r= -.55, p < .005 and r= -.53, p < .005 respectively) (Table 2). High 
scores of the SF-36v2 indicate high levels ofHRQoL while high scores on SyIRS indicate high 
levels of symptom intrusiveness and therefore, low levels of HRQoL. Due to this difference in 
scoring on these two instruments a negative correlation between SyIRS and SF-36v2 suggests 
reliability . 
Reliability - Regression 
In table 3 results of the regression analyses are shown. Regression models with SyIRS as 
DV and demographic variables individually as the IV indicated that none of the IVs are 
significant as a predictor of symptom intrusiveness. In an overall model including all IV s none 
of the IVs predicted symptom intrusiveness, R2 = .05, P < .938. This model including all IVs 
accounted for only 5 % of the variance in SyIRS scores. 
The physical subscale ofSF-36v2, when analyzed as a single IV, accounted for 18% of 
the variance in the results ofSyIRS. The mental subscale ofSF-36v2 as a single IV accounted 
for 25% of the variance. Variance in the SyIRS scores explained by SF-36v2 physical subscale 
increased to 22% and to 29% for the mental subscale when demographic variables were included 
in the model. Demographic variables remained non-significant. 
Discussion 
Cognitive Pretesting 
The participants in cognitive pretesting are not intended to be representative of the 
population being surveyed, but they should have some degree of connection to the topic of the 
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survey (25). A large number of respondents is not essential in conducting cognitive pretesting as 
critical issues with a survey are often identified with a small sample of respondents. Due to the 
number of respondents in this phase of the study and as the respondents were not representative 
of the population of people with chronic symptoms, an analysis of the cognitive pretesting results 
was based on the response of the participants in regards to wording and understanding of the 
survey items, current evidence related to items that assess HRQoL, and the opinion of experts in 
the field ofHRQoL (25). 
Reliability testing 
Reliability testing of Sy IRS included frrst correlating the results of Sy IRS on the initial 
survey administration with the results of SyIRS on the second administration 2 to 4 days later. 
These results indicated a strong positive correlation (.92/.000). Correlation coefficients were also 
calculated based on the results of the first and second administrations of SyIRS and SF-36v2. 
The method of scoring SyIRS and SF-36v2 is an aspect that must be considered in the correlation 
analysis. SF-36v2 scores are presented as the physical component summary (PCS) and the 
mental component summary (MCS). Therefore, the items on SyIRS were categorized as 
physical (SyIRS-p) and mental (SyIRS-m) allowing the PI to perform correlation analysis. Also 
related to scoring, higher scores obtained on SF-36v2 indicate a more positive perception of 
, 
HRQoL. A more positive perception ofHRQoL is reflected in lower scores on SyIRS. 
Therefore, a negative correlation between the results obtained on SyIRS and SF-36v2 confmns a 
certain degree of reliability. ' 
The correlation analysis, using a two-tailed test, indicated a strong negative correlation 
between the results of the physical components ofSyIRS and SF-36v2 on both test and retest, a 
strong negative correlation between the mental component on the first administration of the 
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surveys, and a mOQerate correlation between the mental components on the second retest (Table 
2). The p-value noted in the correlation analysis indicates that the relationships noted in this 
study are not coincidental or obtained·by chance. These results further confrrm the reliability of 
SyIRS in assessing HRQoL. 
Three respondents (6%) in this study were patients at the facility where the study was 
conducted for greater than 2 weeks and completed the retest after 2 weeks while still admitted to 
the facility. Four respondents (8%), who had been discharged prior to 2 weeks, returned the 2 
week retest surveys, as instructed. One respondent (2%) died after the 2 day retest yet before the 
2 week retest. Therefore, the completion rate for retest of the surveys 2 weeks after the initial 
survey completion was 14%. Because the rate was very low, a correlation coefficient was not 
calculated. This result indicates that retest, 2 to 4 weeks after initial administration, is not a 
feasible method to test reliability in a patient population in which a majority are discharged from 
an acute care facility prior to completing retest of an instrument at the recommended time. 
In the regression model, quality of Hfe, as reflected in the scores ofSF .. 36v2 physical and 
mental subscales, explained most of the variance in the model. The independent variables 
contributed minimally to variance in the model. A statistically significant relationship was noted 
between the subscales of SF-36v2 and the results of SyIRS yet not between the results of SyIRS 
and the independent variables. The results of this analysis are limited by the small sample size 
and could potentially lead to a Type II error, failing to reject the null hypothesis or stating there 
is no relationship between the DV and the IV when there could actually be a relationship. Studies 
conducted with a larger sample size are needed to confirm the regression results obtained in this 
study which indicates that none of the IV s are predictors of symptom intrusiveness. 
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Limitations 
A limitation noted in this study is the use of a convenience sample. A problem associated 
with convenience sampling, the weakest form of sampling, is that the subjects available to the PI 
may not be representative of all people experiencing chronic wound pain (29) thus not allowing 
for generalizability of the results. The small sample size in this study is also a limitation. The 
small sample size increased the probability of collecting data that was not reflective of the 
population studied. A larger sample size would provide the ability to correct atypical data that 
may be collected. 
The timing for conducting test-retest ofSyIRS and SF-36v2 was also a limitation. Retest 
was conducted 2 to 4 days after the initial test due to concern that patients would be discharged 
in less than 2 weeks and retest data would not be collected. Conducting retest 2 to 4 days after 
the first test may have led to performance on the first test influencing performance on the second 
test, deliberation on initial responses influencing a person's response on the retest, and variation 
in the administration of the surveys (30). Conducting retest in the recommended time, 2 to 4 
weeks, was a limitation in this study as 86% of the respondents were discharged prior to this time 
and did not complete retest 2 weeks after the initial test as requested. 
There were limitations noted in the cognitive pretesting phase of this study. The PI's 
limited experience and lack of formal education related to cognitive pretesting is a limitation. 
Inherent limitations in the process of cognitive pretesting are the small sample size recruited and 
the potential that the respondents are not representative of the population being studied. 
Conclusion 
The studies investigating chronic wound pain, although limited, have begun to raise 
awareness among RCPs of the complexity of chronic wound pain. RCPs' ability to develop 
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effective treatment/management plans is, in part, dependent upon the quality of assessment. An 
assessment of chronic wound pain can be enhanced by SyIRS, a subjective assessment 
instrument, as it identifies the aspects of a person's HRQoL that are impacted by chronic wound 
pain. A comprehensive assessment will enhance HCPs ability to develop an effective 
management/treatment plan for individuals experiencing chronic wound pain, which can impact 
people in multiple ways enabling them to maintain their desired HRQoL (2). Effectively 
managing chronic wound pain will enable many people to maintain social relationships (27), 
vitality, and mental health (24-26) all which contribute to maintaining or improving a sense of 
well-being and HRQoL (13). 
This pilot study confirms the validity and reliability of SyIRS in a population 
experiencing chronic wound pain. Studies with a larger sample size from this population are 
needed to confirm the predictive power of the IVs on the results ofSyIRS. Further studies 
conducted among patients with varying chronic symptoms are also needed to confirm the 
validity and reliability of SyIRS as a HRQoL assessment instrument. Studies are also needed to 
confirm the interpretation of the scores obtain on SyIRS. 
Key Points 
• Pain has been shown to be the factor with the greatest negative impact on health-related 
quality of life (RRQoL), yet this impact is often not assessed by health care providers 
(RCP) when evaluating patients experiencing chronic wound pain 
• A comprehensive assessment of chronic wound pain includes both an RCP's objective 
assessment and the patient's subjective assessment 
• A comprehensive assessment of chronic wound pain will enhance HCPs' ability to 
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Appendix A Symptom Intrusiveness Rating Scale (SyIRS) 
SYMPTOM INTRUSIVENESS RATING SCALE (SyIRS) 
CIRCLE THE NUMBER THAT DESCRIBES HOW MUCH YOUR SYMPTOM OF AFFECTS THE ITEM LISTED. 
(insert symptom) 
FUNCTIONAL STATUS* never occasionally about half the time frequently always 
\ ) \. ) \... ,) \ J L- J 
+ + + + + 
• Ability to care for yourself 1 2 3 4 5 
(bathing, dressing, eating) 
• Ability to maintain employment 1 2 3 4 5 
• Ability to care for your home 1 2 3 4 5 
(light cleaning, laundry, cooking) 
• Ability to complete errands 1 2 3 4 5 
(shopping, post office) 
• Ability to drive a car or use 1 2 3 4 5 
public transportation 
SOCIAL RELATIONS* never occasionally about half the time frequently always 
\ ) \. ) \.. ,) \ ) \ J 
+ + + + + 
• Ability to visit with family or 1 2 3 4 5 
friends 
• Ability to attend activities outside 1 2 3 4 5 
your home 
(church, social activities, etc.) 
• Ability to participate in pleasurable 1 2 3 4 5 
activities (painting, sports, knitting etc.) 
• Ability to be affectionate (hugs, 1 2 3 4 5 
intimate relations etc.) with those you would like to be 
affectionate with (spouse, children, significant other etc.) 
• Ability to ask friend or family 1 2 3 4 5 
member for assistance 
MENTAL HEALTH* never occasionally about half the time frequently always 
\ ) , ) \.. ) , ) L- ) 
~ ~ ~ ~ ~ 
• Ability to enjoy pleasurable 1 2 3 4 5 
activities 
• Ability to be happy 1 2 3 4 5 
• Ability to manage your outward 1 2 3 4 5 
feelings (crying, anger outbursts, etc.) 
• Ability to think, concentrate, or 1 2 3 4 5 
make decisions 
• Ability to have feelings of 1 2 3 4 5 
self-worth 
* Section heading will not be included in survey given to participants. Items will be randomly ordered. 
Table 1 Respondent Demographics 
AGE :"'L GENDER MARITAL STATUS RAGEIETHNIClTY .. > ... :.: EMPLOYMENT 
N=50 N=5O N=50 N=50 STATUS 
M=58.12 N=50 
SD -17.28 ... 
21-40 22% (11) Male 44% (22) Married/ 54% (27) White 48% (24) Employed 28% (14) 
partner 
41-59 280/0 (14) Female 56% (28) Black 46% (23) Unemployed 30% (15) 
Single 60/0 (3) 
60-79 360/0 (18) White 60/0 ( 3) Retired 42% (21) 
Separated 8% (4) Non-
>80 140/0 (7) Hispanic 
Divorced 20% (10) 
Widowed 120/0(6) 
Table 2 Correlation Table 
SyIRS test-retest Sy IRS/SF-36v2test-retest ~yIRS±p to pcs 
CorrelatiQD/p-value Administration 
.917/.000 Test 
Retest (2-4 days aft~rt~_~!l 
Strong correlation -1.0 to -0.5 or 0.5 to 1.0 




EDUGATION<LEVEL Pain Rating 
N=50 NRS 
N=50 
< 8th grade 2% (1) 0-3 2%(1) 
9-12 grade 380/0 (19) 4-6 600/0(30) 
Some college 42%(21) 7-10 38%(19) 
4 yr college 12% (6) 
Adv college 6% (3) 
------





Table 3 Regression 
e 
-
2 Gender .001 -.026 .857 
3 Race/Ethnici ty .000 .021 .883 
4 Employment status .034 -.185 .198 
5 Education level .021 .143 .321 
6 Marital status .005 .069 .636 
7 Other people in household .001 
8 SF -3 6v2 ohvsical comoonent .177 
nt + Age .064 .253 .076 
11 SF -3 6v2 physical component + Gender .029 .171 .236 
12 SF-36v2 physical component + Race/Ethnicity .001 -.025 .861 
13 SF-36v2 physical component + Employment status .056 .238 .097 
14 SF -3 6v2 physical component + Educational level .000 -.022 .878 
nt + Marital status .003 .057 .695 
17 SF-36v2 mental com onent + A e .053 .231 .107 
18 SF-36v2 mental component + Gender .004 -.065 .652 
19 SF-36v2 mental com onent + Race/Ethnicit .036 -.189 .188 
20 SF-36v2 mental component + Employment status .016 .126 .384 
SF-36v2 mental component + Educational level .016 -.125 .388 
SF-36v2 mental com onent + Marital status .003 
SF-36v2 mental comoonent + Other oeoole in household .037 
e + gender 
25 Model 24 + racelethnicity .027 .025 
26 Model 25 + employment status .037 -.146 .497 
27 Model 26 + educational level .042 .077 .638 
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28 Model 27 + marital status .048 .085 .582 
29 Model 28 + other people in household .051 .057 .719 
. 
30 Model 29 + SF-36v2 physical component .217 -.432 .005 
I 
31 Model 29 + SF-36v2 mental component .287 -.529 _._~99t __ j 
--- - -------
* Sy IRS total score used as dependent variable 
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Conclusion/Summary 
This dissertation addresses several key concepts related to patients with chronic 
conditions; symptom intrusiveness and health-related quality of life (HRQoL). There is a gap in 
the assessment of the impact symptoms of chronic conditions have on health-related quality of 
life. This dissertation focused on developing a conceptual model and a measurement approach to 
the intrusiveness of symptoms on patients with chronic wound pain. This dissertation document 
includes four manuscripts. The first manuscript discusses chronic wound pain, a type of pain that 
is often misunderstood and under-assessed resulting in the lack of effective treatment. This is, in 
part, related to the lack of agreement on how to define chronic wound pain; pain that can be 
acute, for example during dressing changes, and/or chronic throughout the healing process. This 
manuscript identifies the need for further research on the factors related to chronic wound pain 
that impact patients' perceptions of their HRQoL and an effective method for assessing this 
impact. 
Three manuscripts address chronic symptoms and the impact these symptoms have on 
patients' HRQoL. To illustrate this impact, the Chronic Illness Disease States - Symptom 
Intrusiveness Model (CIDS-SIM) was developed. CIDS-SIM is a conceptual model that 
demonstrates that the outcomes of an interaction among nurses, health care providers (HCPs), 
and patients with symptoms associated with chronic conditions will affect patients' perceived 
symptoms intrusiveness, the degree to which patients believe chronic symptoms are impacting 
their HRQoL. Patients' perceptions of symptom intrusiveness will influence the impact they 
determine their symptoms are having on their HRQoL. The perception patients have of their 
HRQoL will then have an impact on further interactions with their HCP. This impact may have 
negative outcomes on effectively managing the symptoms. 
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With a focus on the segment of CIDS-SIM that relates to the perception patients have of 
the impact chronic symptoms have on HRQoL, the Symptom Intrusiveness Rating Scale was 
developed to address the need for an instrument to assess this impact as noted in the third 
map.uscript. SyIRS was developed as a method to subjectively quantify the impact on functional 
status, social relations, and mental health, and the results of the scale are intended to augment 
nurses and HCPs objective assessments of chronic symptoms, enhancing the ability to develop a 
comprehensive assessment and ultimately a more effective treatment plan. 
The results of the study presented in the fourth manuscript in this dissertation indicate 
SyIRS is a HRQoL assessment instrument that has the ability to assess the impact chronic 
symptoms have on patients' HRQoL in a population experiencing chronic wound pain. First, 
results indicate, through cognitive pretesting, that the instructions and statements comprising 
SyIRS are interpreted by those completing the survey as was intended. Next, content validity 
results ind~cated that the statements included in SyIRS are relevant to an assessment ofHRQoL. 
Reliability test results noted a moderate to strong correlation between the results of SyIRS and 
the psychometrically tested SF-36v2 in initial survey completion and a retest 2 to 4 days later. 
Conducting retest 2 weeks after the initial administration was shown to not be a feasible method 
of testing reliability in this population who were inpatients at an acute care facility at the time of 
the initial survey completion yet 94% had been discharged prior to the retest at 2 weeks. Only 
6% of the discharged patients returned the survey as requested. 
Limitations 
Several limitations affect the substantiation of the work in this dissertation. First, only 
one segment ofCIDS-SIM was studied. Multiple areas of this model will require further 
research to confirm the identified factors and the relationship among the factors. The study 
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presented in this dissertation, related to CIDS-SIM, focused on a limited population, those 
experiencing pain associated with chronic wounds. Further research is needed to study SyIRS 
among people with varied symptoms·related to various chronic conditions. The study also 
utilized a convenience sample. Therefore,the respondents in the study may not represent all 
people experiencing pain associated with chronic wounds. Utilizing test retest as a method to 
assess reliability of Sy IRS was also a limitation in this work. The results of the retest 2 to 4 days 
after initial administration may have been influenced by memory of the answers provided on the 
first completion. In addition, the recommended retest interval of 2 to 4 weeks after initial 
a~inistration cannot be utilized in this study design as contact with too many participants is lost 
after patients are discharged. 
Implications for Practice 
The development of CIDS-SIM will assist nurses and other health care providers in 
understanding the factors that influence the perception patients have of the impact of chronic 
symptoms on their HRQoL. The availability of SyIRS, a HRQoL assessment instrument that 
quantifies this impact, will enable nurses and HCPs to comprehensively assess these patients by 
combining the patients' subjective assessment with an objective assessment to enhance the 
k development of an effective treatment plan. SyIRS can also be utilized to assess the effectiveness 
of treatment by allowing nurses and HCPs to observe changes in the results of SyIRS prior to the 
onset of treatment and after treatment has begun, noting if the intended improvement in patients' 
perception of their HRQoL has actually occurred. 
To improve the HRQoL of the increasing number of people with chronic conditions 
seeking their care, nurses who are mainly charged with bedside assessments, are challenged to 
comprehensively assess their patients and contribute to the development of a treatment plan that 
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includes management of the symptoms which their patients indicate are significantly impacting 
their HRQoL. In addressing the patients' perceptions, nurses and Heps can assist patients in 
achieving a state of well-being that patients have defined as acceptable and that allows them to 
function at the level they desire, retain social relationships with those they choose to, and 
maintain a level of mental health they determine is acceptable. 
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Attachment 3 Consent Form 
-Subject Nama: 
-' I Date: 
R .... rch Study Title: Intrusiveness ofpain associated with chronic infected wounds 
(Chronic Wound PainJ 
Study S • Wound Ostomy Continence Nurses Society 
Protocol II: Principallnvesti"ator: 
Jill Monfre .. --
IIMTAIION 
You are Invited to join 8 research study called Chronic Wound Pain .. JUI Monfre RN 
along with Saint Francia Hospital i81n charge of this research study" . 
Participation in this study Is Voluntary .. If you join the stujy. you can change your mind 
and &top at anytime. If you do not want to participate, your present or futures medical 
care' will not change or be any different .. It win not change the help that is available from 
your doctor or Saint Francis Hospital now or in .. future. 
A signed -copy of this consent fonn wilt be a permanent part of your mecltcal record while 
you are in this study. You ¥lill be given a copy of this fonn after it is signed for your 
recorda .. 
You will be required to sign additional Saint Francis Hospital consent forms regarding 
the procedures you will have performed by your Doctor while at Saint Francis Hospital. 
PURPOSE AND BACKGROUND 
The Wound Ostomy ContInence N ..... Society and Udnlycke Health care aponaora 01 this research 
study. You are being tnvIted b take p8rt In thll study because you have a chronic woood and pein. 
Chronic meanllong Jaattng or peralstanl 
The purpose of this study i$ to measure your responses using a survey foruaing on your feeling or 
.~.of: 
(8) weaknesses, 8XpOSUf'8f- or feelngs of helplessness 
(b) shame and loneliness 
(c) symptom control and results 
(d) quality of fife as it relates to long lasUng or slow healing wounds 




This study Includes: 
• A q~nnalre which you can complete )OUtIeff or which can be read to you by the reaeardw 
who will make the answers you choose. Thisquestionnai'e wiI take no more than 20 minutes to 
comptete 
• A review of iQ,H'chart win be done to note the number you rated your pain at and any wound 
cuIttrea already collected 
Because this study is vofuntary you may wI1hdraw or Itop at aTY time and it wilt not change the care 
available from your doctor, or Saint Francis Hospital now or in the future. 
PO IENUAL RISKS 
There is a rare poasiblit¥ d disc:anfort during 1he culture coIection~ 
BENEFITS 
(&Jbjects will not enjoy any PeraonaI benalt from participating in this Research Study. In the future. 
krlo.NIedge gained from the Reseatch Study may help other people.} 
'AI. ~RNATIVES 
You may withdraw Of stop at any time and I wi not change the caJ9 available from ~ doctor. or Saint ". 
Frandl Hoepital ttC1N C6 ."the future. 
COMPENSATION 
. There wli be no compensabto for being i1 this study .. 
. . IN WE OF INJURY 
NA. mlni"nat risk to paUents 
By signing thla fonn you wID not give up any IepI rights. 
'.' The reaea"Ch study wit cover the cost of a wound culture that II not ordered by yru physician 88 pa1 d 
.. your mecIeaI an 
TERMINATION WITHOUT CONSENT 
Your being in this study could be stopped, with or without your.agreement because: 
• .. The Doctor believes it is in your best Interest to stop the study or. 
• It is atD~ by the study sponsor(s). 
• By the FDA. 






~.~~J.f StIlt ...... pt...... a..tcWaundPain iltir~'i ...... "'!!!!!'! 
SRwiWgldtMmCcdJ··ttrr".-.... ,r ,..-" .. 
'I:n any case. the study doctorls1aff will explain to you the reason for your removal froJ;n 
"the study. . 
,,:VOSlS 
Thera ",II be no added coats to you b'takIng part in thisatudy. Saint Francis Hospital 
Wli bill you and your Insurance canter for standard treatment. You wiD be billed for any 
deductlbles or co payments. 
NEW FINDINGS 
NA 
NUMBER OF IUBJECTS 
The number of subjects who wllpartIclpata in the Research Study is estimated to be 
120. 
CONFIDENTIALITY AND AUTH9'R!D)N TO USE AND DISCLOSURE OF 
HEALTH INFORMATION 
ThIs Informed. Consent and Authorization fonn explains use and disclosure of health 
1lformatIon. 
-Informed Consent" tells the purpose of the study. It is designed to give you what you 
need to decide if you want to participate in 8 research study .. It tells how Information, is 
ooQected and how the sponsor will use the study data. ilcluding your health information 
received during the study .. 
"Authorization" refers 1.0 the use and disclosu"e of your health informatJon .. This means 
your doctor, the hospital or clinic. their staff. the Sponsor, its agentst and oontractors 
may see your health information. 
'. b,orderto maintain PrtvaCV. the study staff (individuals working on the study) will use an 
assigned study number and/or inllals,8s Identlier on your study records. Your name 
will not be on study records .. 
Please be aware that representatives of the groups below may see your records to 
. Check research data: . 
• Food and Drug AdmInistration (FDA) . 
• CommIttae lor the Protection of Human Subjects 
• SaInt Francia HospltallRB 
• Wound Ostomy Continence Nurses Society 
• 'Molnlycke Health Care 
COtt=IOENTIAL 
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The FDA and IRe representative can see personal identifiers In your records and VJlII 
Use steps to protect your privacy,. 
" i'" The FDA regulates Sponsor (8) work in developing and assuring safety. qua.faty al1d 
" "perfonnance of its. Drug or DeW::e.. ' 
• The IRB, Is require to watch over the study to make sure it is safe and effective in 
regards to medical products. treatments, and how research Is done at Saint Francis 
Hospital. 
If reports or publications result from this study. you will not be identHied. 
Once your Information is given to the study aponaor8. the tRBIIEC. govemment 
agencIes, or It is a possible that yo .... medical information will be re-dlsclosed and may 
no longer be protec1ed by United States Federal privacy regulations" The laws of your 
,state may provide further prot8ction" Confidentiality will be maintained within the limits 
'oftha law. 
Hyou particIpate In 1he study. you allow the use and disclosure of study findings.. If you 
,do not to authQrize ttlese uses and disclosures of your health information, you wil not 
. be able to participate in the study. 
By signing this consent. you are authorizing such access. 
AUTHORIZATION EXPIRATION DATE 
In signing this form, you allow the use and disclosure of your information for purposes of 
this SWdy at ~y time in the future. ~ 
.. ~THDRAWAL 
Because this study is voluntary you may withdraw or stop at any time and it will not 
change the care available from your doctor. or Saint Francis Hospital now or in the 
future. 
'Any infonnation obtained' before \Nithdrawal ~y be used and disclosed as per this fonn 
by the Sponsor and Researchersco 
(CONTACTS 
':If~ have qu88tiorrs: 
• About the study or feel you have a research study related injury contact 
Jdt Monfre at 765-2019 




Saint Francis Hospital institutional Review Board betvieen 8:30am to 5:00pm at 901 
. J651801. 
In W11tJng: Saint Francis liospitallRB 
% Donna Ryelt ~ Research Site Manager 
5959 Park Avenue 
Memphis. TN 38119 
• your privacy and health information contact: 
Saint Francis Hospital CU$tomer Service from 8:30am to 5:00pm 901.765 .. 1932 
or The Corporate Privacy Office 1-877..egg 8363 Ext. 6709 
. _ of CoDl!Dtand AuthorIzatIon for the Chronic Wound Pain BIIIlrch • 
Study . 
My Signature below IndicateS that I voluntarily agree to join this study and agree to the 
following information: 




.: . The study procedures. risks and benefits, have been explained to me. 
• 1 have been able to ask questions and they have been 8I'WMV8d. 
"';.". ,·1 have read- or had raadto me this consent form; initialed each page and I will 
receive a signed copy" 
• . A copy of this signed oonsent form is required to be on my medical chart while I am 
in Saint Francis Hospital. and on future charts, if I am readmitted to'the hospital 
\Nhile participating in this study. and win be a pennanent part of my medical record. 
• I can refuse to take part or stop being in this study at any time without affecting 
present or future medical care. 
• I voluntarily agree to partiCIpate In this study; I authorize the use and disclosure of 
my medicaJ Information as It is explained in . Ills consent form. 
w.ne a Tile d PenIon a.nne II ..... eor..tand ~ 
.. blIM ...... oto..aan-) 
Page6of8 
Date~ ____ _ 
Date _____ _ 
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Appendix 4 Proteetion of Human Subjects 
Risks to Human Subjects 
a. HU1lUln Subjects Involvement, Characteristics, and Design 
Describe the involvement of human subjects in the work outlined in the Research Strategy 
section. 
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In the proposed study human subjects will complete two (2) surveys, SyIRS and SF-36v2 
and a single face validity question. 
Describe and justify the characteristics of the subject population, including their anticipated 
number, age range, and health status ifrelevant. 
The anticipated number of subjects for this pilot study is 25-50. 
The characteristics of the human subjects in the proposed study include: 
Age 21 years or older due to different methods of assessing the affect of chronic 
symptoms in children and adults and the cognitive ability to complete the surveys. 
Ability to communicate effectively using the English language as the PI is only able to 
communicate in English 
Presence of a chronic wound and experiencing chronic wound pain as the focus of the 
study is related to the specific chronic symptom chronic wound pain. 
Describe and justify the sampling plan, as well as the recruitment and retention strategies and the 
criteria for inclusion or exclusion of any subpopulation. 
As this is a pilot study which is testing the validity and reliability of a survey and there is not 
intent to administer the surveys for this purpose to thousands of individuals, the 
recommended number of subjects is 25-50 (35). The goal of respondent recruitment will be 
to recruit 25-50 subjects representative of diverse gender, ethnic groups and age range. The 
PI will approach potential subjects during the recruitment phase of the study, explain the 
purpose of the study and what will be required of the participant. If the individual agrees to 
participate informed written consent will be obtained. 
Explain the rationale for the involvement of special vulnerable populations, such as fetuses, 
neonates, pregnant women, children, prisoners, institutionalized individuals, or others who may 
be considered vulnerable populations. Note that 'prisoners' includes all subjects involuntary 
incarcerated (for example, in detention centers) as well as subjects who become incarcerated 
after the study begins. 
Special vulnerable populations will not be included in the proposed study. 
If relevant to the research, describe procedures for assignment to a study group. As related to 
human subjects' protection, describe and justify the selection of an intervention's dose, 
frequency, and administration. 
Participants in the proposed study will not be assigned to a study group. 
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List any collaborating sites where human subjects research will be performed, and describe the 
role of those sites and collaborating investigators in performing the research. Explain how data 
from the site(s) will be obtained, managed, and protected. 
Data will only be collected from one acute care facility in Memphis, Tennessee; no other 
sites will be used for this study. 
b. Sources of Materials 
Describe the research material obtained from living individuals in the form of specimens, 
records, or data. 
Information to be obtained from the participants' medical record includes: 
Demographics: age, gender, and race/ethnicity 
History: wound and wound pain 
Wound parameters: size, exudate, periwound condition and wound bed condition 
Pain: intensity and triggers 
Describe any data that will be collected from human subjects for the project(s) described in the 
application. 
Data obtained will include the responses to the SyIRS, SFG-36v2 surveys, and demographic 
information. 
Indicate who will have access to individually identifiable private information about human 
subjects. 
The Pi will have access to identifiable information related to the study participants for the 
purpose of communication with the individuals during the study. No identifiable information 
will be recorded in the study materials. 
Provide information about how the specimens, records, and/or data are collected, managed, and 
protected as well as whether material or data that include individually identifiable private 
information will be collected specifically for the research project. 
The surveys utilized in this study can be completed: 
1. By the participant utilizing the paper survey and pencil OR 
2. If requested by the participant, the PI will read the instructions, questions, and 
possible answers to the participant and record the participant's response on the survey 
form 
A master list of the names of participants will be compiled for identification for re-
administration of the SyIRS. The master list will only be available to the researcher. 
Participants will be assigned a random number for data entry purposes. Study materials will 
be stored in a locked cabinet in the office of the PI. 
c. Potential Risks 
Describe the potential risks to subjects (physical, psychological, financial, legal, or other), and 
assess their likelihood and seriousness to the human subjects. 
There are not identified risks to study participants. 
Where appropriate, describe alternative treatments and procedures, including the risks and 
potential benefits of the alternative treatments and procedures, to participants in the research. 
There are no alternative treatments or procedures related to the proposed study. 
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Appendix 5 Cognitive Pretesting Manual 
DIRECTIONS 
When initially approaching a potential 
participant the following script will be 
used 
If the individual does not want to 
participate. 
If the individual agrees to participate 
If the patient will complete the surveys in 
his or her hospital room 
At the predetermined time, take the 
participant to the identified location or 
meet with patient in his or her hospital 
room if that is where the patient will 
complete the surveys, for completion of 
cognitive pretesting. Have available a 
copy of the survey and a pencil. 
Ask the participant 
The interviewer will be aware, from the 
medical record review, if the patient is 
able to drink liquids and will ask this 
question only if the patient is allowed to 
drink 
When the respondent is comfortable 
show the respondent the survey and give 
the instructions -
. VERBAL COMMENTS 
"Hello (potential participant' s name) . My name is 
------
. In addition to my role at the hospital, I am a nurse 
researcher and a doctoral student at the Medical University of South 
Carolina. I am conducting a study that will include patients admitted to 
the hospital. As part of this study I need to determine if what I intend by 
the items that are included in a survey the patients will be completing is 
how people interpret the items. If you agree to participate there will be 
no compensation and I can assure you that I will not record any 
personnel information that will identify you. Your participation will 
take less than one hour. Participating in this part of the study will help 
us in developing a survey that accurately reflects how chronic 
symptoms affect a person's health related quality of life. Would you be 
willing to participate in this phase of the study by reading the items on 
the survey and answering questions regarding what you think the 
meaning of the item is?" 
"(Individual's name) ____________ thank you for your 
time" 
"(Individual's name) thank you for 
agreeing to participate in this study. 
The room where the testing will be completed is available to us 
(note when room is available) and I am available 
-------
---------
(PI will note when she is available). When 
would be a convenient time for you to complete this phase of the 
study?" 
I am available (PI will note when she is 
available). When would be a convenient time for you to complete this 
phase of the study?" 
"Is there anything I can do to make you more comfortable?" 
"Would you like something to drink?" 
"Please read the directions for completing the study at the top of the 
first page" 
Circle the number that 
describes how your symptom 
of affects the 
item listed. 
The answer category for all 
items which the respondent 
will see on the survey is: 
1- never 
2 - occasionally 
3 - about half the time 
4 - frequently 
5 - most of the time 
1-ability to care for yourself 
When the survey is conducted the 
symptom being experience by the 
person completing the survey will 
be inserted in the blank space. 
1. Please tell me in your 
own words what these 
instructions mean to 
? 
I will now ask you about each 
item on the survey; I will indicate 
which item I am referring to by 
the number of the item on the 
survey. After you read the item 
and select your response I will ask 
you 2-3 questions regarding the 
item. 
Do you have any questions 
Pr 1 - what does "care for yourself' mean to you 
2-ability to maintain employment 
Pr 1 - what does ';'maintain employment" mean to you 
Pr 2 - does this item apply to you 
3-ability to care for your home 
Pr 1 - what does "care for your home" mean to you 
Pr 2 - how easy or hard was it for you to select a response to this item 
4-a bility to com plete errands 
Pr 1 - what does complete errands mean to you 
5-ability to ~rive a car or use public transportation 
Pr 1 - what does "ability to drive" mean to you 
Pr 2 - what does "ability to use public transportation" mean to you 
Pr3 - was it easy or hard for you to select a response while considering both 
of these activities 
6-ability to visit with family or friends 
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Pr 1 - what does "ability to visit" mean to you 
Pr 2 - what were you thinking as you selected a response to this item 
'-ability to attend activities outside your home 
Pr 1 - what does "activities outside your home" mean to you 
Pr 2 - what were you considering as you selected a response to this 
question 
8-ability to participate in pleasurable activities 
Pr 1 - please repeat this question in your own words 
Pr 2 - how did you select your response 
9-ability to be affectionate with those you would like to be affectionate 
with 
Pr 1 - what does "affectionate" mean to you 
Pr 2 - is it ok to have this item in this survey 
IO-ability to ask friends or family members for assistance 
Pr 1 - tell me in your own words what this item is stating 
11- ability to enjoy pleasurable activities 
Pr 1 - what does "enjoy pleasurable activities" mean to you 
Pr 2 - what were you thinking as you selected your answer to this item 
12-ability to be happy 
Pr 1 - what does "happy" mean to you 
Pr 2 - how easy or hard was it to select a response to this item 
13-ability to manage your outward feelings 
Pr 1 - what does "outward feelings" mean to you 
Pr 2 - what does "manage" mean to you in this item 
14-ability to think, concentrate, and make decisions 
Pr 1 - what does "think" mean to you 
Pr 2 - what does "concentrate" mean to you 
Pr 3 - what does "make decisions" mean to you 
Pr 4 - how easy or hard was it for you to select a response with think, 
concentrate, and make decisions in the same item 
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IS-ability to have feelings of self-worth 
Pr 1 - what does "self .. worth" mean to you 
Pr 2 - was it easy or hard for you to select a response to this item 
Neutral probes that can be asked by the interviewer when 
it is appropriate include 
• Tell me more 
• What do you mean 
At conclusion of cognitive pretesting 
• Is there more you would like to add 
"(Participant name) thank you for 
participating in this interview. What you have said to me 
here will be combined with what other people has said. 
This survey will be revised according to those responses. I 
appreciate you assistance 
1 8 
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Ability to care for your home What does care for your home "Clean my house" 
mean to you "Maintain my house" 
"Cleaning, laundry" 
Ability to manage your What does outward feelings "Not being irritable" 
outward feelings mean to you "Not showing emotion" 
"N ot balling" 
Ability to think, concentrate, What does think, concentrate, "Able to focus" 
and make decisions make decisions mean to you "U sing your head" 
Ability to care for yourself What does care for yourself "Take a shower" 
mean to you "Put on my clothes" 
"Do my hair" 
Appendix 7 Interview Manual for Survey Administration 
Script for interviewers on how to introduce study (researcher's directions are italicized, 
scripts are in bold) 
When initially approaching a potential participant for consent to participate in this study, the 
following script will be used 
"BeUo Mr.lMrs./Ms./Miss • My name is • I am a nurse 
researcher and a doctoral student at the Medical University of South Carolina. I am 
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conducting a study about how your symptom of (insert symptom) can affect 
your HRQoL. This study involves completing 2 surveys at three separate times; once within 
the next 24 hours tben in 2-4 days and the last time will be in approximately 2 weeks. The 
last time the surveys will be eo_pleted here if you are still. patieDt or tbe surveys can be 
taken home for you to co.plete and lend back to me iD • stamped, addressed.envelope that 
I will provide to you. Each time youeolDplete the surveys should take approximately 30 
minutes so your total time wiD be approximately one and a half hours. If you would like to 
participate in this study, I will first have you sign the consent form and then I will review 
your medical record to see if you meet the conditions to participate. Once I have fmished a 
review of your medical record, twill come back and let you know if you meet the 
conditions to partieipate or not. If you have met the conditions I wlll provide the surveys 
and pencils for you to complete the surveys. I want to assure you tlaat I will Dot record any 
penonal informatioD that will identify you as I complete aDY part of &his study. If you agree 
to participate iD this study it will not change any of your current treatments". 
If after reviewing the medical record, the person DOES NOT meet the criteriafor the study, the 
following script will be used. 
"Mr./MrsJMs./Miss thank you for agreeing to participate in 
this study. I am sorry, but you did Dot meet the conditions to be included iD this study. 
Please be aSlured that I did not record any personal information about you as I reviewed 
your medical record. Again, thank you for your time." 
If after reviewing the medical record, the person DOES meet criteria for the study, the following 
script will be used 
"Mr .JMrs./Ms.lMiss thank you for agreeing to participate in 
this study. You have met the conditions necessary to participate in this study." 
When a potential participant meets the criteria continue below -
Take the participant to the identified location for completion of the questionnaire. If appropriate 
ask the participant 
HIs there anything I can do to make you more comfortable?" 
Provide what you are able to for the comfort of the participant 
Provide the respondent with the Symptom Intrusiveness Rating Scale and two pencils 
Continue with -
"Please read the instructions and clearly mark you answer by circling the number which 
indicates the degree your pain interferes with the activity iD the item. I will stay in the room 
until you have completed the questionnaire." 
Questions you may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not allowed to explain the questions, answer the questions as best you can. " 
Document in the study notes any questions participants ask. 
After the participant has completed SyIRS, provide the respondent with the SF-36v2 -
"Please read the instructions and· clearly' .ark you answer by completely rdling in the 
eirele to indicate your response. I will stay in the 'room until you have eompleted the 
questionnaire." 
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Questions you may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not aDowed toesplaiD the questions, answer the questions as best you can. " 
After the respondent has completed the surveys -
"Mr.lMrs.lMs.lMiss I appreciate you taking the time today to 
participate in this study. Your aDswen will be combined with othen in the study to look 
more closely at how symptoms can affeet a penon's HRQoL. I wiH return in 2-4 days for 
you to complete the surveys for the second part of this study. 
Escort the respondent to their requested area. 
At the time of the second adlllinistration of the survey 
"HeDo, Mr./Mrs./Ms./Miss thank you again for agreeing to 
participate in the study being I am OODductiDg about how your wound pain is impacting on 
your life. Is this' a cODvenient time for you to complete the ,survey again?" 
If the patient indicates that it is not a convenient time -
"What time would be more convenient for you?" 
When determining a more convenient time note that the surveys are to be completed the second 
time within 2-4 days after the first completion. 
If the patient indicates that the time is convenient provide the patient with a copy ofSyIRS and a 
pencil and continue with -
" As you did when you fint eompleted the surveys, please read the instructions and clearly 
mark you answer by eireting the number whieh indicates the degree your pain interferes 
with the activity in the item. I will stay in the room until you have completed the 
questionnaire. " 
Questions I may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not aHowed to explain the questions, answer the questions as best you can. " 
I will document in the study notes any questions participants ask. 
After the participant has completed SyIRS, provide the respondent with the SF-36v2 -
"Please read the instructions and clearly mark you.answer by completely ,.dling in the 
circle to indieate your response. I will stay in the room untH you have completed the 
ClaestioDnaire. " 
Questions I may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not aHowed to explain the questions, answer the questions as best you can." 
After the respondent has completed the surveys -
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"Mr.lMrs.lMs.IMiss I appreciate you taking the time today to 
participate in this study. The next time the surveys are to be completed are in about 2 
weeks. If you are discharged before that time, I will give you copies of the surveys with the 
week noted that I will need you to complete the surveys. I will also give you a stamped self 
addressed envelope to return the surveys to me in. If you are still in the hospital at the time 
for the surveys to be completed again, I will come to your room for you to complete them. 
Escort the respondent to their requested area. 
At the time of the third administration of the survey, if the patient is an inpatient 
"Hello, Mr./Mrs.lMs./Miss thank you again for agreeing to 
participate in the study being I am condueting about how your wound pain is impacting on 
your life. Is this a convenient time for you to complete the survey apin?" 
If the patient indicates that it is not a convenient time -
"What time would be more convenient for you?" 
When determining a more convenient time note that the surveys are to be completed the second 
time within 2-4 days after the first completion. 
If the patient indicates that the time is convenient provide the patient with a copy ofSyIRS and a 
pencil and continue with -
"As you did when you completed the other surveys, please read the instructions and clearly 
mark you answer by circling the number which indicates the degree your pain interferes 
with the activity in the item. I will stay in the room until you have completed the 
questioDnaire. " 
Questions I may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not allowed to explain the questions, answer the questions as best you can." 
I will document in the study notes any questions participants ask. 
After the participant has completed 8ylRS, provide the respondent with the SF-36v2 -
"Please read the instructions and clearly mark you answer by completely filling in the 
circle to indicate your response. I will stay in the room until you have completed the 
questionnaire. " 
Questions I may answer during the survey include those related to the method to complete the 
questionnaire (e.g. How do I mark the answer I want to pick?). If a participant asks the meaning 
of a specific question respond by saying -
"I am not allowed to explain the questions, answer the questions as best you can." 
After the respondent has completed the surveys -
"Mr.lMrs.lMs.lMiss I appreciate you taking the time today to 
participate in this study. The next time the surveys are to be completed are in about 2 
weeks. If you are discharged before that time, I will give you copies of the surveys with the 
week noted that I will need you to complete the surveys. I will also give you a stamped self 
addressed envelope to return the surveys to me in. If you are still in the hospital at the time 
for the surveys to be completed again, I will come to your room for you to complete them. 
Escort the responde'}t to their requested area. 
If the patient is to be discharged in less than 2-4 weeks after the first administration of the 
surveys -
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"HeUo, Mr.lMrs.lMs.lMiss tbank you again for agreeing to 
participate in the study being I am conducting about how your wound pain is impacting on 
your life. , undentand that you are being discharged. The last time for completing the 
surveys will be after you are at home. I have tbe surveys here for you with the week that I 
would like for you to eomplete the surveys. I would appreciate if you would complete the 
surveys the week of (indicate the date of the first day of the week to complete the surveys). 
Complete the surveys as you have already done by reading the instructions and circling 
your answer on the Symptom Intrusiveness Rating Scale and by completely filling in the 
eircle on tbe SF-35v2 survey. I also have for you a stamped addressed envelope for you to 
return the surveys to me in. I would like to thank you very much for participating in this 
study. Your answers will be combined with others in the study to look more closely at how 
symptoms can affect a person's HRQoL." 
Reminder call for subjects who are to complete the 2-4 week post first administration surveys 
after discharge 
"HeUo, Mr.lMn.lMs.lMiss • I am calling from (hospital name) 
about the study you participated in wllUe you were admitted here. I am calling to remind 
you to please complete the surveys and man them to me in the envelope I sent home with 
you. Do you think you will be able to rut out tile surveys? 
If already completed 
"Thank you very much Mr.lMrs.lMs.lMiss _______ - I appreciate your 
contribution to this study_ Have a nice day" 
If not yet completed 
"I would appreciate if you could complete the surveys and mail them back to me this week. 
Your input is important to the results of this study. Thank you and have a nice day" 
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